<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cell Death Dis</journal-id><journal-id journal-id-type="iso-abbrev">Cell Death Dis</journal-id><journal-title-group><journal-title>Cell Death &#x00026; Disease</journal-title></journal-title-group><issn pub-type="epub">2041-4889</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23846224</article-id><article-id pub-id-type="pmc">3730424</article-id><article-id pub-id-type="pii">cddis2013253</article-id><article-id pub-id-type="doi">10.1038/cddis.2013.253</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>ROS-mediated platelet generation: a microenvironment-dependent manner for megakaryocyte proliferation, differentiation, and maturation</article-title><alt-title alt-title-type="running">ROS engage in the regulation of thrombocytopoiesis</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chen</surname><given-names>S</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Su</surname><given-names>Y</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><xref ref-type="aff" rid="aff1">,1</xref><xref ref-type="corresp" rid="caf1">*</xref></contrib><aff id="aff1"><label>1</label><institution>College of Preventive Medicine, State Key Laboratory of Trauma and Burns and Combined Injury, Institute of Combined Injury of PLA, Chongqing Engineering Research Center for Nanomedicine, College of Preventive Medicine, Third Military Medical University</institution>, Chongqing 400038, <country>People's Republic of China</country></aff></contrib-group><author-notes><corresp id="caf1"><label>*</label><institution>College of Preventive Medicine, State Key Laboratory of Trauma and Burns and Combined Injury, Institute of Combined Injury of PLA, Third Military Medical University Chongqing</institution>, Chongqing 400038, <country>China</country>. Tel: +86 23 68752283; Fax: +86 23 68752283; E-mail: <email>wangjunping@tmmu.edu.cn</email> or <email>wangjunp@yahoo.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>07</month><year>2013</year></pub-date><pub-date pub-type="epub"><day>11</day><month>07</month><year>2013</year></pub-date><pub-date pub-type="pmc-release"><day>1</day><month>7</month><year>2013</year></pub-date><volume>4</volume><issue>7</issue><fpage>e722</fpage><lpage/><history><date date-type="received"><day>15</day><month>04</month><year>2013</year></date><date date-type="rev-recd"><day>03</day><month>06</month><year>2013</year></date><date date-type="accepted"><day>04</day><month>06</month><year>2013</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2013 Macmillan Publishers Limited</copyright-statement><copyright-year>2013</copyright-year><copyright-holder>Macmillan Publishers Limited</copyright-holder><license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0/"><!--author-paid--><license-p>This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/</license-p></license></permissions><abstract><p>Platelets have an important role in the body because of their manifold functions in haemostasis, thrombosis, and inflammation. Platelets are produced by megakaryocytes (MKs) that are differentiated from haematopoietic stem cells via several consecutive stages, including MK lineage commitment, MK progenitor proliferation, MK differentiation and maturation, cell apoptosis, and platelet release. During differentiation, the cells migrate from the osteoblastic niche to the vascular niche in the bone marrow, which is accompanied by reactive oxygen species (ROS)-dependent oxidation state changes in the microenvironment, suggesting that ROS can distinctly influence platelet generation and function in a microenvironment-dependent manner. The objective of this review is to reveal the role of ROS in regulating MK proliferation, differentiation, maturation, and platelet activation, thereby providing new insight into the mechanism of platelet generation, which may lead to the development of new therapeutic agents for thrombocytopenia and/or thrombosis.</p></abstract><kwd-group><kwd>reactive oxygen species</kwd><kwd>megakaryocytopoiesis</kwd><kwd>platelet activation</kwd><kwd>microenvironment</kwd><kwd>regulation</kwd></kwd-group></article-meta></front><body><sec><title>Facts</title><p><list list-type="bullet"><list-item><p>Platelet production is a consecutive process beginning with haematopoietic stem cell (HSC) proliferation and ending with the fragmentation of megakaryocytes (MKs). This process occurs in a microenvironment called the &#x02018;niche'.</p></list-item><list-item><p>Reactive oxygen species (ROS) affect the fate of HSCs by regulating the ROS-phosphatidylinositol-3-kinase (PI3K)/Akt-transcription factor forkhead box O (FOXO)-3 and ROS-p38 mitogen-activated protein kinase <italic>&#x003b1;</italic> (MAPK<italic>&#x003b1;</italic>) pathways.</p></list-item><list-item><p>P22<sup>phox</sup>-dependent nicotinamide-adenine dinucleotide phosphate oxidase (NOX)-1 may be responsible for ROS generation in the regulation of MK commitment and differentiation.</p></list-item><list-item><p>Platelet production is a result of MK apoptosis, which may be caused by elevated levels of ROS.</p></list-item></list></p></sec><sec><title>Open Questions</title><p><list list-type="bullet"><list-item><p>Which NOX isoform is responsible for the different stages of thrombocytopoiesis, including MK proliferation, differentiation, maturation, and fragmentation?</p></list-item><list-item><p>Where is the boundary between the physiological and pathophysiological effects of ROS on MK differentiation and platelet activation?</p></list-item><list-item><p>What is the relationship between ROS and cytokine&#x02013;receptor signalling during MK differentiation?</p></list-item></list></p><p>Approximately 1 &#x000d7; 10<sup>11</sup> platelets are produced by MKs every day in the human body.<sup><xref ref-type="bibr" rid="bib1">1</xref>, <xref ref-type="bibr" rid="bib2">2</xref></sup> The best-known function of platelets is their response to blood vessel injury, in which they change shape, secrete granule contents, and aggregate to prevent blood loss. In addition, studies have shown that platelets also have an important role in several other processes, such as inflammation, neoangiogenesis, innate immunity, and tumour metastasis.<sup><xref ref-type="bibr" rid="bib3">3</xref>, <xref ref-type="bibr" rid="bib4">4</xref>, <xref ref-type="bibr" rid="bib5">5</xref>, <xref ref-type="bibr" rid="bib6">6</xref></sup> Platelets are produced during several stages involving the commitment of HSCs to the MK lineage, MK progenitor proliferation, MK differentiation and maturation, and platelet release from mature MKs as a consequence of apoptosis<sup><xref ref-type="bibr" rid="bib7">7</xref>, <xref ref-type="bibr" rid="bib8">8</xref></sup> (<xref ref-type="fig" rid="fig1">Figure 1</xref>). As reported previously, thrombocytopoiesis is regulated by a variety of haematopoietic cytokines, such as thrombopoietin (TPO), granulocyte&#x02013;macrophage colony-stimulating factor (GM-CSF), interleukin family proteins (IL-1, IL-3, IL-6, and IL-11), and stromal cell-derived factor-1 (SDF-1).<sup><xref ref-type="bibr" rid="bib9">9</xref>, <xref ref-type="bibr" rid="bib10">10</xref>, <xref ref-type="bibr" rid="bib11">11</xref>, <xref ref-type="bibr" rid="bib12">12</xref>, <xref ref-type="bibr" rid="bib13">13</xref></sup> However, the mechanisms underlying MK differentiation and platelet generation under physiological and pathological conditions have not been adequately elucidated.</p><p>Research over the past 20 years has demonstrated that reactive oxygen species (ROS) have an essential role in certain cellular events.<sup><xref ref-type="bibr" rid="bib14">14</xref></sup> Nicotinamide-adenine dinucleotide phosphate (NADPH) oxidases (NOXs) is regarded as an important intercellular producer of ROS.<sup><xref ref-type="bibr" rid="bib15">15</xref></sup> However, beside NOXs, ROS may be generated as by-products, such as superoxide anion leaked from mitochondrial respiratory chain, hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) generated by phagocytic oxidases(PHOX) in the plasma membrane, and hypochlorous acid catalyzed by myeloperoxidase in activated neutrophils.<sup><xref ref-type="bibr" rid="bib16">16</xref>, <xref ref-type="bibr" rid="bib17">17</xref></sup> In addition, other enzyme systems, including xanthine oxidoreductase, cyclooxygenase, uncoupled nitric oxide (NO) synthases, <italic>P</italic>450 mono-oxygenase, and lipoxygenase, have also been identified as potential ROS donors.<sup><xref ref-type="bibr" rid="bib18">18</xref>, <xref ref-type="bibr" rid="bib19">19</xref>, <xref ref-type="bibr" rid="bib20">20</xref></sup> ROS can affect pathogen defences, post-translational protein processing, gene expression regulation, and cell signalling and differentiation.<sup><xref ref-type="bibr" rid="bib15">15</xref></sup> Recently, studies have suggested that ROS are also involved in both MK development and platelet activation. The objective of this article is to review and identify the properties and functions of ROS in regulating MK differentiation and maturation, and platelet production and activation. We believe that this article will provide additional information regarding megakaryocytopoiesis and platelet generation.</p></sec><sec><title>Oxidation State of the Bone Marrow Microenvironment: An Important Determinant for HSC Fate</title><p>In 1978, Schofield<sup><xref ref-type="bibr" rid="bib21">21</xref></sup> proposed the HSC &#x02018;niche' model for the physiological microenvironment of HSCs. Later, studies provided evidence that niche is just a site composed of heterologous cell types that created three-dimensional structure for stem cell residing.<sup><xref ref-type="bibr" rid="bib22">22</xref></sup> Recently, a new definition for niche is proposed as a composition of two stem cells: HSCs and osteoprogenitor, with the latter contributing to the cavity formation, sinusoid development, and osteoblast and adipocyte production, thereby embodying different functional cues for HSCs in turn.<sup><xref ref-type="bibr" rid="bib23">23</xref></sup> So far, it is widely recognised that niche is a regulatory system that controls HSCs' activity from their surroundings, including supporting cells and their secreted factors, nervous system, and oxygen, and so on.<sup><xref ref-type="bibr" rid="bib24">24</xref>, <xref ref-type="bibr" rid="bib25">25</xref>, <xref ref-type="bibr" rid="bib26">26</xref></sup> In recent years, increasing studies of the niche have focused on its important role in determining stem cell fate with regard to self-renewal <italic>versus</italic> differentiation.<sup><xref ref-type="bibr" rid="bib22">22</xref>, <xref ref-type="bibr" rid="bib27">27</xref>, <xref ref-type="bibr" rid="bib28">28</xref>, <xref ref-type="bibr" rid="bib29">29</xref></sup> Two components of the niche have been identified for the different HSC activity states: the osteoblastic niche and the vascular niche. The osteoblast lining of the endosteal surface is an important component of the osteoblastic niche, and the adhesion of HSCs to osteoblasts is a critical molecular mechanism for maintaining quiescent HSCs.<sup><xref ref-type="bibr" rid="bib30">30</xref>, <xref ref-type="bibr" rid="bib31">31</xref></sup> Haematopoietic cells and endothelial cells are the two elements of the vascular niche, which is the site for the proliferation and differentiation or maturation of HSCs into circulation.<sup><xref ref-type="bibr" rid="bib32">32</xref>, <xref ref-type="bibr" rid="bib33">33</xref>, <xref ref-type="bibr" rid="bib34">34</xref></sup></p><p>HSC distribution in the niche is closely associated with O<sub>2</sub> tension.<sup><xref ref-type="bibr" rid="bib35">35</xref></sup> The endosteal surface of the niche has the lowest O<sub>2</sub> level,<sup><xref ref-type="bibr" rid="bib36">36</xref></sup> where primitive HSCs are maintained in the quiescent state (G<sub>0</sub>). It is known that 0.1&#x00025; O<sub>2</sub> prevents CD34<sup>&#x0002b;</sup> cells from entering into the cell cycle.<sup><xref ref-type="bibr" rid="bib37">37</xref></sup> Furthermore, hypoxia augments the colony-forming potential of human haematopoietic progenitor cells and their potential to differentiate into MKs, because 1&#x00025; O<sub>2</sub> could not only promote the proliferation of CD34<sup>&#x0002b;</sup> cells but also increase the expression of CD41<sup><xref ref-type="bibr" rid="bib38">38</xref></sup> (<xref ref-type="fig" rid="fig2">Figure 2</xref>). In addition, altered superoxide within stromal cells might lead to abnormal survival and development of haematopoietic cells in the myelodysplastic marrow microenvironment,<sup><xref ref-type="bibr" rid="bib39">39</xref></sup> and higher levels of H<sub>2</sub>O<sub>2</sub> secreted from stromal cells in the bone marrow (BM) could be detected with lower peroxiredoxin 2 expression in the haematopoietic niche,<sup><xref ref-type="bibr" rid="bib40">40</xref></sup> further suggesting that the niche can regulate the activity of HSCs in an ROS-dependant manner.</p><p>HSCs also modulate several molecules to adapt to the hypoxic environment, such as glycolytic and oxidative repair proteins, which protect them from oxygen radicals.<sup><xref ref-type="bibr" rid="bib41">41</xref></sup> Furthermore, HSCs can regulate the level of hypoxia-inducible factor-1<italic>&#x003b1;</italic>,<sup><xref ref-type="bibr" rid="bib42">42</xref></sup> accompanied by the increased expression of Tie-1 and vascular endothelial growth factor, which adjusts the O<sub>2</sub> gradient to promote HSC homing to the niche.<sup><xref ref-type="bibr" rid="bib43">43</xref>, <xref ref-type="bibr" rid="bib44">44</xref></sup> Specifically, HSC/progenitor cell compartment showed an approximately 27-fold expansion under a 5&#x00025; O<sub>2</sub> atmosphere. However, less expansion and cell cycle activation suppression were observed under normoxic conditions.<sup><xref ref-type="bibr" rid="bib45">45</xref></sup> Because it is widely believed that oxidative metabolism generates ROS, these results indicate that low levels of ROS may contribute to HSC quiescence and self-renewal, whereas the gradual increase of ROS is associated with HSC expansion. However, an increase in ROS beyond a certain level will harm HSCs because of toxic effects.</p><p>Several studies have suggested that ROS may participate in or enhance the intracellular signalling of HSCs in either a quiescent or proliferative state. Mdm2, a gene coding for an E3 ubiquitin ligase,<sup><xref ref-type="bibr" rid="bib46">46</xref></sup> Abbas <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib47">47</xref></sup> reported that basal ROS accumulated and p53 activity increased during HSC development when Mdm2 was knocked out, and p53 could further increase ROS production by transactivating p53-induced genes (PIG). As <italic>Mdm2</italic> has the ability to control p53 in a low level, which is critical for cellular homeostasis and allows for stem cell survival,<sup><xref ref-type="bibr" rid="bib47">47</xref></sup> it is taken as an important factor to regulate ROS levels during normal haematopoiesis. ROS overaccumulation can also be prevented by nuclear factor-&#x003ba;B (NF-<italic>&#x003ba;</italic>B) and the antioxidant activity of NF-<italic>&#x003ba;</italic>B is considered to be indispensable for the development of haematopoietic progenitor cells, as Flk-1<sup>&#x0002b;</sup> cells (putative haemangioblasts) expressing dominant-negative Rel/NF-<italic>&#x003ba;</italic>B (I<italic>&#x003ba;</italic>BSR) exhibited higher apoptosis through increasing ROS accumulation.<sup><xref ref-type="bibr" rid="bib48">48</xref></sup></p><p>The FOXO is also required for the quiescence and homeostasis of HSCs because it maintains a low threshold of intracellular ROS levels.<sup><xref ref-type="bibr" rid="bib49">49</xref>, <xref ref-type="bibr" rid="bib50">50</xref>, <xref ref-type="bibr" rid="bib51">51</xref></sup> Notably, activated AKT (protein kinase B) directly phosphorylated FOXO, leading to increased ROS production and FOXO-3 mobilization to the nucleus when ROS accumulated. This was accompanied by cell proliferation.<sup><xref ref-type="bibr" rid="bib50">50</xref></sup> Elevated ROS levels also induce HSC-specific p38 MAPK<italic>&#x003b1;</italic> phosphorylation, followed by defects in HSC maintenance,<sup><xref ref-type="bibr" rid="bib52">52</xref></sup> whereas activated p38 MAPK<italic>&#x003b1;</italic> further promotes ROS production to expand CD133<sup>&#x0002b;</sup> cells.<sup><xref ref-type="bibr" rid="bib53">53</xref></sup> These results suggest that PI3K/Akt-FOXO-3 signalling and p38 MAPK<italic>&#x003b1;</italic> pathway have an important role in the ROS-dependent regulation of HSC expansion. In addition, ROS also appear to affect other functions of HSCs because murine Lin<sup>&#x02212;</sup>c-Kit<sup>&#x0002b;</sup> cells deficient in NOX2 showed impaired chemotaxis, invasion, and actin reorganisation when exposed to SDF-1,<sup><xref ref-type="bibr" rid="bib54">54</xref></sup> whereas <italic>N</italic>-acetylcysteine (NAC) (an ROS scavenger) treatment suppressed the mobilisation of HSCs.<sup><xref ref-type="bibr" rid="bib55">55</xref></sup></p><p>Besides ROS, the thiol balance is also reported to contribute to the myeloproliferation and haematopoietic progenitor cell mobilisation, as redox status can be regulated by free or protein-incorporated thiols.<sup><xref ref-type="bibr" rid="bib56">56</xref></sup> Interestingly, a shift in the thiol&#x02013;disulphide equilibrium sustained by the glutathione/thioredoxin will occur in early steps during differentiation, which makes the committing cells more proficient to handle an increased level of ROS.<sup><xref ref-type="bibr" rid="bib57">57</xref></sup></p><p>In conclusion, HSCs are maintained in a quiescent state for self-renewal in the osteoblastic niche with low levels of ROS via the regulation of p53 levels, NF-<italic>&#x003ba;</italic>B activity, and with thiol balance. Whereas in a more oxygenated environment, HSCs and other progenitor cells actively proliferate, migrate, and differentiate. This is partly due to the effect of ROS on HSC development through the regulation of the ROS-PI3K/Akt-FOXO-3 and ROS-p38 MAPK<italic>&#x003b1;</italic> pathways, and the shift of thiol&#x02013;disulphide equilibrium (<xref ref-type="fig" rid="fig3">Figure 3</xref>).</p></sec><sec><title>Significance of ROS in the Lineage Commitment of HSCs to MKs</title><p>HSCs proliferate and differentiate into all haematopoietic lineages after they lose their self-renewal capacity in response to various extracellular or intracellular agonists. Specifically, ROS act on the differentiation phase of HSCs into MKs, as addition of the antioxidant 6-hydroxy-2,5,7,8-1 tetramethylchroman-2-carboxylic acid (Trolox) and NAC inhibited the acquisition of MK morphological features and significantly lowered the levels of the MK markers CD41, CD42b, and CD61 induced by TPO.<sup><xref ref-type="bibr" rid="bib58">58</xref></sup> In addition, 5&#x00025; O<sub>2</sub> increased the total number of MKs and CFU-MKs from CD34<sup>&#x0002b;</sup> cells.<sup><xref ref-type="bibr" rid="bib59">59</xref></sup> Sardina <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib58">58</xref></sup> observed that p22<sup>phox</sup> NOX-dependent complexes had an important role in regulating ROS production during megakaryocytopoiesis. NOX1 may be the most abundant NOX isoform in MKs and may be upregulated by TPO, and TPO-stimulated ROS levels can be abrogated by an NOX inhibitor, diphenyliodonium (DPI).<sup><xref ref-type="bibr" rid="bib60">60</xref></sup></p><p>However, the mechanism through which ROS activate the signalling cascades required for MK commitment remains unclear. Previous studies have suggested that exogenous ROS could increase the tyrosine phosphorylation of the common <italic>&#x003b2;</italic>c and signal transducers and activators of transcription-5 (STAT5). Moreover, the tyrosine residues of other signalling molecules, including c-KIT, the adapter protein SHC, and the protein tyrosine phosphatase SHP-1, were also phosphorylated after H<sub>2</sub>O<sub>2</sub> stimulation in the MK cell line MO7e.<sup><xref ref-type="bibr" rid="bib61">61</xref></sup> These results indicate that a change in the redox state increases the tyrosine phosphorylation of cellular proteins. The effect of ROS on phosphatase inhibition, which regulates these signalling pathways, may be a significant mechanism of MK commitment because PP1<italic>&#x003b1;</italic> inhibition by ROS constitutively activates the PI3K/AKT pathway in leukaemic cells.<sup><xref ref-type="bibr" rid="bib62">62</xref></sup></p><p>The effect of ROS on the mitogen-activated protein kinase/extracellular signal-regulated kinase (MEK)-extracellular signal-regulated kinase (ERK) 1/2 pathway may be another possible mechanism underlying MK commitment. ERK activation in K562 and HEL cells induced by phorbol myristate acetate during MK differentiation was also inhibited by ROS inhibitors.<sup><xref ref-type="bibr" rid="bib58">58</xref></sup> Furthermore, MEK-ERK1/2 signalling was shown to have a critical role in MK commitment and differentiation because inhibition of the MEK-ERK1/2 pathway with two structurally distinct MEK inhibitors (UO126 and PD186141) increased the expression of the immature marker CD34<sup>&#x0002b;</sup> and decreased the expression of the late MK commitment marker GPIb (CD42b).<sup><xref ref-type="bibr" rid="bib63">63</xref></sup> In addition, inhibition of the MEK-ERK1/2 pathway caused a leftward shift of the ploidy in BM and foetal liver-derived primary MKs, showing a critical requirement for the MEK-ERK1/2 pathway in MK differentiation from HSCs.<sup><xref ref-type="bibr" rid="bib63">63</xref></sup> These results indicate that ROS may be a vital regulator that acts on different signalling pathways during megakaryocytic development. Regrettably, the details of the mechanism of ROS in regulating cellular signalling pathways during megakaryocytic development have not been fully uncovered.</p></sec><sec><title>The Role of ROS in Regulating MK Proliferation and Differentiation</title><p>Recent studies have shown that ROS promote the proliferation of many cell types.<sup><xref ref-type="bibr" rid="bib64">64</xref>, <xref ref-type="bibr" rid="bib65">65</xref>, <xref ref-type="bibr" rid="bib66">66</xref>, <xref ref-type="bibr" rid="bib67">67</xref>, <xref ref-type="bibr" rid="bib68">68</xref></sup> Moreover, ROS are increased in a cell cycle-dependent manner and oscillated with every cell division, indicating that ROS may also affect cell cycle progression.<sup><xref ref-type="bibr" rid="bib69">69</xref></sup> Notably, it has been shown that MK differentiation from HSCs occurs in the osteoblastic niche, which is partially attributed to the close relationship between ROS and MKs<sup><xref ref-type="bibr" rid="bib70">70</xref></sup> (<xref ref-type="fig" rid="fig3">Figure 3</xref>).</p><p>Stimulating human haematopoietic cells with GM-CSF, IL-3, stem cell factor, or TPO, which act on different stages of megakaryocytopoiesis,<sup><xref ref-type="bibr" rid="bib71">71</xref>, <xref ref-type="bibr" rid="bib72">72</xref></sup> will trigger ROS production. High H<sub>2</sub>O<sub>2</sub> concentrations can increase intracellular ROS levels, which is accompanied by several events, including G1- to S-phase cell cycle progression, c-fos gene expression, and cell migration. Surprisingly, the ROS levels and signal activation were decreased when cells were treated with the antioxidant pyrrolidine dithiocarbamate, indicating a role of ROS signalling in MK proliferation.<sup><xref ref-type="bibr" rid="bib61">61</xref></sup></p><p>Specifically, ROS are upstream of the signalling cascades required for MK proliferation and differentiation, because DPI could inhibit the activation of AKT, STAT3, and STAT5, which are hypothesised to be necessary for MK differentiation.<sup><xref ref-type="bibr" rid="bib58">58</xref></sup> Furthermore, in p22<sup>phox</sup> knocked-down cells, ERK, STAT-5, and AKT activations were also significantly lower.<sup><xref ref-type="bibr" rid="bib58">58</xref></sup> ROS also regulate the activation or induction of transcription factors, including p53, NF-kB, and activation protein-1 (AP-1). The family of JUN/FOS transcription factors and the regulation of AP-1 by redox processes show that ROS also mediate the function of AP-1 in MK growth and proliferation.<sup><xref ref-type="bibr" rid="bib73">73</xref></sup> Furthermore, glycolysis activation is a critical step for ROS production because the glucose transport rate is one of the first responses following ligand&#x02013;receptor interactions,<sup><xref ref-type="bibr" rid="bib74">74</xref></sup> and ROS production is tightly coupled with glucose metabolism.<sup><xref ref-type="bibr" rid="bib75">75</xref></sup> However, inhibition of glucose utilisation could decrease ROS production induced by TPO in a PI-3K/AKT-dependent manner in UT-7/TPO cells.<sup><xref ref-type="bibr" rid="bib76">76</xref></sup></p><p>During the unique endomitosis (a specific phenomenon characterised with abortion of mitosis in late anaphase and failure of cytokinesis followed by reinitiation of DNA synthesis) and polyploidisation processes of MK development, the cell size induced by TPO was greater under higher O<sub>2</sub> tension conditions,<sup><xref ref-type="bibr" rid="bib77">77</xref></sup> and the MKs also showed a higher ploidy under high O<sub>2</sub> tension conditions.<sup><xref ref-type="bibr" rid="bib59">59</xref></sup> This suggests that endomitosis and polyploidisation are closely related to ROS levels. Specifically, in endomitosis and polyploidisation development, ROS may mediate the progression of G1&#x02013;S phase by regulating G1 cyclin gene expression,<sup><xref ref-type="bibr" rid="bib78">78</xref></sup> and NOX inhibitors can downregulate the effects of cyclins D3 and E on MK polyploidisation.<sup><xref ref-type="bibr" rid="bib79">79</xref></sup></p><p>As reported, cyclin D3 is the predominant D-type cyclin because it can induce high ploidy levels in cyclin D3 transgenic mice and the ablation of cyclin D3 in cultured MKs can significantly decrease MK ploidy.<sup><xref ref-type="bibr" rid="bib80">80</xref>, <xref ref-type="bibr" rid="bib81">81</xref></sup> Cyclin E is also a G1-phase cell cycle regulator and has been suggested to have a role in MK ploidy promotion, which has been shown in megakaryoblastic K562 cell re-replication cycles.<sup><xref ref-type="bibr" rid="bib82">82</xref></sup> The ploidy levels in NOX-inhibited MKs were partially restored when cyclin E was upregulated, which further supports the involvement of cyclin E in MK polyploidisation through the G1/S-phase regulation.<sup><xref ref-type="bibr" rid="bib60">60</xref></sup> However, NOX1-deficient mice displayed no differences in MK ploidy compared with wild-type mice, whereas NOX inhibitors could cause a significant decrease in the ploidy of MKs. This indicates that NOX1 alone is not necessary for MK polyploidisation.<sup><xref ref-type="bibr" rid="bib60">60</xref></sup></p></sec><sec><title>Role of ROS in MK Maturation and Platelet Release</title><p>Mature MKs are in proximity to the BM sinusoid space or lung capillaries, where there is a high level of O<sub>2</sub>, and that MKs can release platelets into the sinus in this region.<sup><xref ref-type="bibr" rid="bib83">83</xref></sup> An increase in either O<sub>2</sub> tension or ROS promotes the maturation of MKs.<sup><xref ref-type="bibr" rid="bib84">84</xref></sup> Early studies of thrombopoiesis showed that CD34<sup>&#x0002b;</sup> peripheral blood cells generated more CD41<sup>&#x0002b;</sup> MKs under 20&#x00025; <italic>p</italic>O<sub>2</sub> than under 5&#x00025; <italic>p</italic>O<sub>2</sub> conditions<sup><xref ref-type="bibr" rid="bib59">59</xref></sup> and that MK differentiation under 20&#x00025; <italic>p</italic>O<sub>2</sub> was associated with increased expression of the MK maturation-specific transcription factors GATA-1 and NF-E2.<sup><xref ref-type="bibr" rid="bib85">85</xref></sup> Of the two transcription factors, GATA-1 was shown to interact with either RUNX1 or FOG-1 to promote MK differentiation and affect cytoplasmic maturation before platelet release.<sup><xref ref-type="bibr" rid="bib86">86</xref></sup> NF-E2 may coordinate with other genes that reorganise the cytoskeleton and transport organelles into proplatelets to regulate platelet release because NF-E2-null mice did not undergo proplatelet formation.<sup><xref ref-type="bibr" rid="bib87">87</xref></sup> Therefore, it is hypothesised that MK maturation is closely related to the cellular response to oxidative stress.</p><p>However, platelet generation is also associated with NO, which is constitutively produced by endothelial cells. Reports have shown that exogenous and endogenous forms of NO induce apoptosis in MKs.<sup><xref ref-type="bibr" rid="bib88">88</xref></sup> Battinelli <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib89">89</xref></sup> observed that, in the human megakaryocytoid cell line Meg-01, NO-induced apoptosis was associated with the terminal stages of megakaryocytopoiesis, including proplatelet formation, platelet release, and, ultimately, MK death. Notably, studies indicated that NO was easily inactivated by O<sub>2</sub> to form another type of ROS, ONOO<sup>&#x02212;</sup>.<sup><xref ref-type="bibr" rid="bib90">90</xref></sup> ONOO<sup>&#x02212;</sup> activates upstream effectors of ERK, such as MAPK/ERK,<sup><xref ref-type="bibr" rid="bib91">91</xref></sup> which substantially increases thrombopoiesis during the last phase of MK development. Therefore, NO may interact with O<sub>2</sub><sup>&#x02212;</sup> to form ROS, which act during the final stage of MK maturation in an ERK-dependent manner. This may be a possible explanation for the effect of ROS on MK maturation and platelet release (<xref ref-type="fig" rid="fig3">Figure 3</xref>).</p><p>In addition, there appears to be an inner transcriptional mechanism through which ROS accumulation promotes MK maturation. Nrf2, a Cap'N'Collar (CNC) transcription factor, confers cytoprotection against oxidative stress through heterodimerisation with small Maf proteins.<sup><xref ref-type="bibr" rid="bib92">92</xref>, <xref ref-type="bibr" rid="bib93">93</xref>, <xref ref-type="bibr" rid="bib94">94</xref></sup> It was reported that the expressions of Nrf2-targeted genes involved in the stress response were decreased during MK maturation. This suggests that MKs may reduce the concentration of antioxidant proteins during maturation, which facilitates MK development by using ROS accumulation as a maturation signal.<sup><xref ref-type="bibr" rid="bib95">95</xref></sup> Another CNC transcription factor, p45, which is a component of NF-E2,<sup><xref ref-type="bibr" rid="bib96">96</xref></sup> has a critical role in megakaryocytic maturation and platelet production,<sup><xref ref-type="bibr" rid="bib97">97</xref></sup> as proplatelet formation was completely defective in <italic>p45</italic>-null MKs.<sup><xref ref-type="bibr" rid="bib87">87</xref></sup> A recent study indicated that the increase in p45 could promote ROS accumulation and full activation of the platelet genes that promote thrombocytopoiesis.<sup><xref ref-type="bibr" rid="bib98">98</xref></sup></p><p>In addition, studies have shown that ROS generation is increased during the terminal phase of platelet production. For example, the transcription factors associated with MK maturation, GATA-1, NF-E2, and mammalian target of rapamycin, were all increased and that this increase was accompanied by increased ROS production when Toll-like receptor-2 (TLR2) activated, which is reported to express on MKs.<sup><xref ref-type="bibr" rid="bib99">99</xref>, <xref ref-type="bibr" rid="bib100">100</xref></sup> Therefore, it is postulated that TLR2 drives MK maturation through ROS production. Another transcription factor, peroxisome proliferator-activated receptor <italic>&#x003b3;</italic>, is also found to be present in both MKs and platelets,<sup><xref ref-type="bibr" rid="bib101">101</xref></sup> and the treatment with its ligand, 15-deoxy-<sup>&#x025b5;12,14</sup>-prostaglandin J<sub>2</sub> (15d-PGJ<sub>2</sub>), may enhance the proplatelet formation.<sup><xref ref-type="bibr" rid="bib84">84</xref></sup> Further investigation revealed that the effect of 15d-PGJ<sub>2</sub> was associated with the modulation of intracellular ROS levels in MKs, because 15d-PGJ<sub>2</sub>-induced platelet production was partially blocked with antioxidants.<sup><xref ref-type="bibr" rid="bib84">84</xref></sup> Moreover, the observation that reduced MK apoptosis and platelet production were accompanied by a decrease in total ROS levels in the cells suggested that ROS were also involved in MK apoptosis to generate platelets.<sup><xref ref-type="bibr" rid="bib102">102</xref></sup> Taken together, these results suggest that ROS had an important role in MK maturation and/or subsequent proplatelet formation.</p></sec><sec><title>Close Correlation between ROS and Platelet Activation</title><p>Platelets that circulate in the bloodstream under normal conditions will actively adhere to and spread on the collagen matrix if the vascular endothelial layer is injured. ROS are also involved in this process as well as platelet aggregation and recruitment, because blocking superoxide production could suppress platelet activation and aggregation.<sup><xref ref-type="bibr" rid="bib103">103</xref>, <xref ref-type="bibr" rid="bib104">104</xref>, <xref ref-type="bibr" rid="bib105">105</xref></sup> However, there remains some controversy regarding the mechanism by which oxidants affect platelet function.<sup><xref ref-type="bibr" rid="bib106">106</xref></sup></p><p>Collagen-induced platelet aggregation was associated with H<sub>2</sub>O<sub>2</sub> release, which acts as a second messenger by stimulating the arachidonic acid metabolism and phospholipase C pathways,<sup><xref ref-type="bibr" rid="bib107">107</xref>, <xref ref-type="bibr" rid="bib108">108</xref></sup> suggesting that there are potential sources of ROS in platelets themselves. Further studies suggested that platelet aggregation may be partially mediated by the NOX system and phospholipase A2-activated arachidonic acid metabolism, and protein kinase C may modulate both pathways.<sup><xref ref-type="bibr" rid="bib109">109</xref></sup> The nicotinamide adenine dinucleotide oxidase Ecto-NOX1 has been described in human platelets, and ROS production triggered by ligand&#x02013;receptor interactions could thereby enhance the expression and activity of Ecto-NOX1. Therefore, it is hypothesised that redox regulation of Ecto-NOX1 may have a significant role in platelet activation and recruitment.<sup><xref ref-type="bibr" rid="bib110">110</xref></sup></p><p>However, it is unclear how ROS function within platelets. Earlier studies demonstrated that rapid platelet activation was induced by the acute inhibition of endogenous NO production <italic>in vivo</italic>,<sup><xref ref-type="bibr" rid="bib111">111</xref></sup> whereas ROS may partially modulate platelet function by attenuating NO bioavailability via ONOO<sup>&#x02212;</sup> generation.<sup><xref ref-type="bibr" rid="bib112">112</xref></sup> Recent studies indicated that ONOO<sup>&#x02212;</sup> can react with tyrosyl residues to form 3-NO<sub>2</sub>-Tyr and with thiols to generate S-nitrosothiols, which reduces the inhibitory effect of NO. In addition, ONOO<sup>&#x02212;</sup> may act as a substrate for COX peroxidase, leading to prostaglandin endoperoxide H synthase activation and increased prostaglandin formation.<sup><xref ref-type="bibr" rid="bib113">113</xref></sup> These reactions are important for platelet-derived thromboxane A2 synthesis.<sup><xref ref-type="bibr" rid="bib114">114</xref></sup> Moreover, platelet-derived ONOO<sup>&#x02212;</sup> can lead to the production of 8-iso-PGF<sub>2a</sub> from arachidonic acid,<sup><xref ref-type="bibr" rid="bib115">115</xref></sup> whereas 8-iso-PGF<sub>2a</sub> may increase calcium release from intracellular stores, induce platelet shape change, and amplify platelet aggregation in response to agonists.<sup><xref ref-type="bibr" rid="bib113">113</xref></sup> Furthermore, ONOO<sup>&#x02212;</sup> is likely to enhance the bioavailability of adenosine diphosphate, thereby increasing additional platelet recruitment.<sup><xref ref-type="bibr" rid="bib115">115</xref></sup></p><p>ROS production affects <italic>&#x003b1;</italic>IIb<italic>&#x003b2;</italic>3 activation because NOX inhibitors and superoxide scavengers may reduce platelet aggregation and <italic>&#x003b1;</italic>IIb<italic>&#x003b2;</italic>3 activation.<sup><xref ref-type="bibr" rid="bib116">116</xref></sup> In addition, ROS could also increase platelet adhesion to the vascular endothelium by acting on transcriptional mechanisms in the endothelium, degrading the endothelial glycocalyx, and inactivating endothelial ectonucleotidases.<sup><xref ref-type="bibr" rid="bib117">117</xref></sup> It is hypothesised that platelet agonists, such as thrombin, collagen, and thromboxane, can activate NOX, thereby causing intracellular ROS accumulation and affecting several phases of platelet activation (<xref ref-type="fig" rid="fig4">Figure 4</xref>). In turn, platelets may release superoxide anions into the bloodstream as autocrine messengers, which will be involved in further platelet activation and recruitment to thrombus formation sites.<sup><xref ref-type="bibr" rid="bib115">115</xref></sup></p></sec><sec><title>ROS-Related Therapeutic Strategies for Thrombocytopenia and Thrombosis</title><p>Because ROS can influence the function and activity of various molecules involved in the commitment, proliferation, differentiation of MKs, and platelet release, as well as platelet activation and aggregation (<xref ref-type="fig" rid="fig4">Figure 4</xref>), this characteristic of ROS makes them interesting therapeutic targets for regulating megakaryocytopoiesis and platelet function. Indeed, modulating ROS levels has previously been shown to be a promising strategy for treating the abnormal decrease or increase in platelet count under pathological conditions. The two opposing strategies for treating abnormal platelet numbers are to either decrease or increase ROS levels accordingly.</p><p>As reviewed, the gradual rise in ROS levels is tightly related to MK development. Therefore, increasing the level of ROS either through the enhancement of ROS generation or inhibition of intracellular antioxidants will provide potential therapeutic avenues for rescuing thrombocytopenia. For instance, the ability of 15d-PGJ<sub>2</sub> to increase MK ploidy and proplatelet formation and to promote platelet recovery after ionising radiation is primarily attributed to its capacity to induce ROS formation.<sup><xref ref-type="bibr" rid="bib84">84</xref></sup> Further investigation revealed that inhibiting haem oxygenase-1 activity could enhance 15d-PGJ<sub>2</sub>-induced platelet production.<sup><xref ref-type="bibr" rid="bib118">118</xref></sup> Moveover, arsenic trioxide (ATO), a miracle drug for the treatment of relapsed acute promyelocytic leukaemia, also displayed a haemostatic effect, probably due to the fact that ATO could enhance either mitochondrial ROS generation or NOX activation through the inhibition of thioredoxin and increase the permeability of the mitochondrial membrane.<sup><xref ref-type="bibr" rid="bib119">119</xref>, <xref ref-type="bibr" rid="bib120">120</xref></sup> It is known that currently, as the main treatment for thrombocytopenia, platelet transfusion is expensive, time-consuming, risky, and has limited efficacy (alloimmunisation).<sup><xref ref-type="bibr" rid="bib121">121</xref></sup> Hence, it is desirable to develop ROS-dependent agents for the treatment of thrombocytopenia.</p><p>An abnormal increase in platelets and activation leads to other types of diseases, such as thrombosis and atherosclerosis,<sup><xref ref-type="bibr" rid="bib122">122</xref>, <xref ref-type="bibr" rid="bib123">123</xref>, <xref ref-type="bibr" rid="bib124">124</xref></sup> which are accompanied by increased intraplatelet ROS production.<sup><xref ref-type="bibr" rid="bib125">125</xref>, <xref ref-type="bibr" rid="bib126">126</xref>, <xref ref-type="bibr" rid="bib127">127</xref>, <xref ref-type="bibr" rid="bib128">128</xref></sup> Therefore, decreasing ROS levels may be an effective strategy for treating these types of diseases. Recently, several agents were found to exert therapeutic potential to such diseases via ROS depression. For example, phloroglucinol (1,3,5-trihydroxybenzene; 1,3,5-benzenetriol), a bioactive compound, was shown to have antithrombotic and profibrinolytic effects through directly inhibiting ROS production.<sup><xref ref-type="bibr" rid="bib129">129</xref>, <xref ref-type="bibr" rid="bib130">130</xref></sup> Chang <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib131">131</xref></sup> further demonstrated that the effect of phloroglucinol in attenuating arachidonic acid-induced platelet aggregation was closely related to a decrease in ROS production. Astaxanthin was also proved to have encouraging therapeutic effects on atherosclerosis, probably by inhibiting oxidative stress, including reducing the ROS production.<sup><xref ref-type="bibr" rid="bib132">132</xref></sup></p><p>H<sub>2</sub>O<sub>2</sub> is reported to be involved in the development of atherosclerotic vascular disease and regulates atherosclerotic plaque stability under pathological conditions.<sup><xref ref-type="bibr" rid="bib133">133</xref></sup> Therefore, inhibition of the source of H<sub>2</sub>O<sub>2</sub> production, such as NOX, is another promising therapeutic strategy. Several agents, such as apocynin and Pefabloc, have been shown to block oxidase assembly.<sup><xref ref-type="bibr" rid="bib134">134</xref>, <xref ref-type="bibr" rid="bib135">135</xref>, <xref ref-type="bibr" rid="bib136">136</xref></sup> Noticeably, studies have also suggested that the p47phox subunit is most likely a clinically safer target than other NOX subunits that are required for enzyme activity.<sup><xref ref-type="bibr" rid="bib137">137</xref></sup> Therefore, the p47phox subunit of NOX will be a primary target for treating such diseases in the future.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>The field of thrombopoiesis research is currently growing, and our understanding of the molecular basis of megakaryocytopoiesis has progressed substantially, as MKs were first found to give rise to platelets in 1906. The role of ROS in MK biology has increasingly drawn attention in recent years. Despite great advances in the knowledge that ROS has an important role in platelet production and activation, the precise cell signalling events and mechanisms underlying the regulation of ROS are not completely understood.</p><p>Other important issues remain to be addressed, and we hope that researchers will be inspired to determine where the boundary lies between the physiological and pathophysiological effects of ROS on thrombopoiesis and platelet activation. These results will provide new insights into ROS-based platelet production. The mechanism through which ROS affect MK biology and cytokine&#x02013;receptor signalling, including downstream molecules, must be precisely and thoroughly investigated because the current studies on ROS effects on megakaryocytopoiesis are limited. In addition, the study of ROS will certainly provide new therapeutic targets for the treatment of abnormal platelet counts and activation, which is critical for the development of new drugs to treat platelet-related diseases.</p></sec></body><back><ack><p>We thank Michelle Meredyth-Stewart for grammar revision of this manuscript. This work was supported by grants from the National Natural Science Fund of China (No. 31071025), the National &#x02018;863' High-tech Development Plan (No. 2007AA02Z152), the Special Fund from PLA (No. BSW11J009), the Key Basic Research and Development Plan of China (No. 2012CB518103), and the Funds of Key Laboratory of Trauma, Burn, and Combined Injury (Nos. SKLZZ201115, SKLZZ201016, and SKLKF200911).</p></ack><glossary><def-list><def-item><term>AP-1</term><def><p>activation protein-1</p></def></def-item><def-item><term>ATO</term><def><p>arsenic trioxide</p></def></def-item><def-item><term>BM</term><def><p>bone marrow</p></def></def-item><def-item><term>CNC</term><def><p>Cap'N'Collar</p></def></def-item><def-item><term>DPI</term><def><p>diphenyliodonium</p></def></def-item><def-item><term>ERK</term><def><p>extracellular signal-regulated kinase</p></def></def-item><def-item><term>FOXO</term><def><p>transcription factor forkhead box O</p></def></def-item><def-item><term>GM-CSF</term><def><p>granulocyte&#x02013;macrophage colony-stimulating factor</p></def></def-item><def-item><term>H<sub>2</sub>O<sub>2</sub></term><def><p>hydrogen peroxide</p></def></def-item><def-item><term>HSCs</term><def><p>haematopoietic stem cells</p></def></def-item><def-item><term>MAPK</term><def><p>mitogen-activated protein kinase</p></def></def-item><def-item><term>MEK</term><def><p>mitogen-activated protein kinase/extracellular signal-regulated kinase</p></def></def-item><def-item><term>MK</term><def><p>megakaryocyte</p></def></def-item><def-item><term>NAC</term><def><p><italic>N</italic>-acetylcysteine</p></def></def-item><def-item><term>NF-<italic>&#x003ba;</italic>B</term><def><p>nuclear factor-<italic>&#x003ba;</italic>B</p></def></def-item><def-item><term>NO</term><def><p>nitric oxide</p></def></def-item><def-item><term>NOX</term><def><p>nicotinamide-adenine dinucleotide phosphate oxidase</p></def></def-item><def-item><term>PHOX</term><def><p>phagocytic oxidases</p></def></def-item><def-item><term>PI3K</term><def><p>phosphatidylinositol-3-kinase</p></def></def-item><def-item><term>ROS</term><def><p>reactive oxygen species</p></def></def-item><def-item><term>SDF-1</term><def><p>stromal cell-derived factor-1</p></def></def-item><def-item><term>STAT</term><def><p>signal transducers and activators of transcription</p></def></def-item><def-item><term>TLR</term><def><p>Toll-like receptor</p></def></def-item><def-item><term>TPO</term><def><p>thrombopoietin</p></def></def-item><def-item><term>15d-PGJ<sub>2</sub></term><def><p>15-deoxy-<sup>&#x025b5;12,14</sup>-prostaglandin J<sub>2</sub></p></def></def-item></def-list></glossary><fn-group><fn><p>Edited by A Finazzi-Agr&#x000f2;</p></fn></fn-group><notes><p>The authors declare no conflict of interest.</p></notes><ref-list><ref id="bib1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bluteau</surname><given-names>D</given-names></name><name><surname>Lordier</surname><given-names>L</given-names></name><name><surname>Di Stefano</surname><given-names>A</given-names></name><name><surname>Chang</surname><given-names>Y</given-names></name></person-group><article-title>Regulation of megakaryocyte maturation and platelet formation</article-title><source>J Thromb Haemost</source><year>2009</year><volume>7</volume><fpage>227</fpage><lpage>234</lpage><pub-id pub-id-type="pmid">19630806</pub-id></mixed-citation></ref><ref id="bib2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thon</surname><given-names>JN</given-names></name><name><surname>Italiano</surname><given-names>JE</given-names></name></person-group><article-title>Platelet formation</article-title><source>Semin Hematol</source><year>2010</year><volume>47</volume><fpage>220</fpage><lpage>226</lpage><pub-id pub-id-type="pmid">20620432</pub-id></mixed-citation></ref><ref id="bib3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenne</surname><given-names>CN</given-names></name><name><surname>Urrutia</surname><given-names>R</given-names></name><name><surname>Kubes</surname><given-names>P</given-names></name></person-group><article-title>Platelets: bridging hemostasis, inflammation, and immunity</article-title><source>Int J Lab Hematol</source><year>2013</year><volume>35</volume><fpage>254</fpage><lpage>261</lpage><pub-id pub-id-type="pmid">23590652</pub-id></mixed-citation></ref><ref id="bib4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tantry</surname><given-names>US</given-names></name><name><surname>Bliden</surname><given-names>KP</given-names></name><name><surname>Suarez</surname><given-names>TA</given-names></name><name><surname>Kreutz</surname><given-names>RP</given-names></name><name><surname>Dichiara</surname><given-names>J</given-names></name><name><surname>Gurbel</surname><given-names>PA</given-names></name></person-group><article-title>Hypercoagulability, platelet function, inflammation and coronary artery disease acuity: results of the Thrombotic RIsk Progression (TRIP) study</article-title><source>Platelets</source><year>2010</year><volume>21</volume><fpage>360</fpage><lpage>367</lpage><pub-id pub-id-type="pmid">20377327</pub-id></mixed-citation></ref><ref id="bib5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>W</given-names></name><name><surname>Madajka</surname><given-names>M</given-names></name><name><surname>Kerr</surname><given-names>BA</given-names></name><name><surname>Mahabeleshwar</surname><given-names>GH</given-names></name><name><surname>Whiteheart</surname><given-names>SW</given-names></name><name><surname>Byzova</surname><given-names>TV</given-names></name></person-group><article-title>A novel role for platelet secretion in angiogenesis: mediating bone marrow-derived cell mobilization and homing</article-title><source>Blood</source><year>2011</year><volume>117</volume><fpage>3893</fpage><lpage>3902</lpage><pub-id pub-id-type="pmid">21224474</pub-id></mixed-citation></ref><ref id="bib6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gay</surname><given-names>LJ</given-names></name><name><surname>Felding-Habermann</surname><given-names>B</given-names></name></person-group><article-title>Contribution of platelets to tumour metastasis</article-title><source>Nat Rev Cancer</source><year>2011</year><volume>11</volume><fpage>123</fpage><lpage>134</lpage><pub-id pub-id-type="pmid">21258396</pub-id></mixed-citation></ref><ref id="bib7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reems</surname><given-names>JA</given-names></name><name><surname>Pineault</surname><given-names>N</given-names></name><name><surname>Sun</surname><given-names>S</given-names></name></person-group><article-title><italic>In vitro</italic> megakaryocyte production and platelet biogenesis: state of the art</article-title><source>Transfus Med Rev</source><year>2010</year><volume>24</volume><fpage>33</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">19962573</pub-id></mixed-citation></ref><ref id="bib8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Botton</surname><given-names>SD</given-names></name><name><surname>Sabri</surname><given-names>S</given-names></name><name><surname>Daugas</surname><given-names>E</given-names></name><name><surname>Zermati</surname><given-names>Y</given-names></name><name><surname>Guidotti</surname><given-names>JE</given-names></name><name><surname>Kroemer</surname><given-names>G</given-names></name><etal/></person-group><article-title>Platelet formation is the consequence of caspase activation within megakaryocytes</article-title><source>Blood</source><year>2002</year><volume>100</volume><fpage>1310</fpage><lpage>1317</lpage><pub-id pub-id-type="pmid">12149212</pub-id></mixed-citation></ref><ref id="bib9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sasaki</surname><given-names>H</given-names></name><name><surname>Hirabayashi</surname><given-names>Y</given-names></name><name><surname>Ishibashi</surname><given-names>T</given-names></name><name><surname>Inoue</surname><given-names>T</given-names></name><name><surname>Matsuda</surname><given-names>M</given-names></name><name><surname>Kai</surname><given-names>S</given-names></name><etal/></person-group><article-title>Effects of erythropoietin, IL-3, IL-6 and LIF on a murine megakaryoblastic cell line: growth enhancement and expression of receptor mRNAs</article-title><source>Leuk Res</source><year>1995</year><volume>19</volume><fpage>95</fpage><lpage>102</lpage><pub-id pub-id-type="pmid">7869746</pub-id></mixed-citation></ref><ref id="bib10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burstein</surname><given-names>SA</given-names></name><name><surname>Mei</surname><given-names>RL</given-names></name><name><surname>Henthorn</surname><given-names>J</given-names></name><name><surname>Friese</surname><given-names>P</given-names></name><name><surname>Turner</surname><given-names>K</given-names></name></person-group><article-title>Leukemia inhibitory factor and interleukin-11 promote maturation of murine and human megakaryocytes <italic>in vitro</italic></article-title><source>J Cell Physiol</source><year>1992</year><volume>153</volume><fpage>305</fpage><lpage>312</lpage><pub-id pub-id-type="pmid">1429851</pub-id></mixed-citation></ref><ref id="bib11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neben</surname><given-names>TY</given-names></name><name><surname>Loebelenz</surname><given-names>J</given-names></name><name><surname>Hayes</surname><given-names>L</given-names></name><name><surname>McCarthy</surname><given-names>K</given-names></name><name><surname>Stoudemire</surname><given-names>J</given-names></name><name><surname>Schaub</surname><given-names>R</given-names></name><etal/></person-group><article-title>Recombinant human interleukin-11 stimulates megakaryocytopoiesis and increases peripheral platelets in normal and splenectomized mice</article-title><source>Blood</source><year>1993</year><volume>81</volume><fpage>901</fpage><lpage>908</lpage><pub-id pub-id-type="pmid">8427998</pub-id></mixed-citation></ref><ref id="bib12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pang</surname><given-names>L</given-names></name><name><surname>Weiss</surname><given-names>MJ</given-names></name><name><surname>Poncz</surname><given-names>M</given-names></name></person-group><article-title>Megakaryocyte biology and related disorders</article-title><source>J Clin Invest</source><year>2005</year><volume>115</volume><fpage>3332</fpage><lpage>3338</lpage><pub-id pub-id-type="pmid">16322777</pub-id></mixed-citation></ref><ref id="bib13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Majka</surname><given-names>M</given-names></name><name><surname>Janowska-Wieczorek</surname><given-names>A</given-names></name><name><surname>Ratajczak</surname><given-names>J</given-names></name><name><surname>Kowalska</surname><given-names>MA</given-names></name><name><surname>Vilaire</surname><given-names>G</given-names></name><name><surname>Pan</surname><given-names>ZK</given-names></name><etal/></person-group><article-title>Stromal-derived factor 1 and thrombopoietin regulate distinct aspects of human megakaryopoiesis</article-title><source>Blood</source><year>2000</year><volume>96</volume><fpage>4142</fpage><lpage>4151</lpage><pub-id pub-id-type="pmid">11110685</pub-id></mixed-citation></ref><ref id="bib14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valko</surname><given-names>M</given-names></name><name><surname>Leibfritz</surname><given-names>D</given-names></name><name><surname>Moncol</surname><given-names>J</given-names></name><name><surname>Cronin</surname><given-names>MT</given-names></name><name><surname>Mazur</surname><given-names>M</given-names></name><name><surname>Telser</surname><given-names>J</given-names></name></person-group><article-title>Free radicals and antioxidants in normal physiological functions and human disease</article-title><source>Int J Biochem Cell Biol</source><year>2007</year><volume>39</volume><fpage>44</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">16978905</pub-id></mixed-citation></ref><ref id="bib15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bedard</surname><given-names>K</given-names></name><name><surname>Krause</surname><given-names>KH</given-names></name></person-group><article-title>The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology</article-title><source>Physiol Rev</source><year>2007</year><volume>87</volume><fpage>245</fpage><lpage>313</lpage><pub-id pub-id-type="pmid">17237347</pub-id></mixed-citation></ref><ref id="bib16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reiter</surname><given-names>RJ</given-names></name><name><surname>Tan</surname><given-names>DX</given-names></name><name><surname>Mayo</surname><given-names>JC</given-names></name><name><surname>Sainz</surname><given-names>RM</given-names></name><name><surname>Leon</surname><given-names>J</given-names></name><name><surname>Czarnocki</surname><given-names>Z</given-names></name></person-group><article-title>Melatonin as an antioxidant: biochemical mechanisms and pathophysiological implications in humans</article-title><source>Acta Biochim Pol</source><year>2003</year><volume>50</volume><fpage>1129</fpage><lpage>1146</lpage><pub-id pub-id-type="pmid">14740000</pub-id></mixed-citation></ref><ref id="bib17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giorgio</surname><given-names>M</given-names></name><name><surname>Trinei</surname><given-names>M</given-names></name><name><surname>Migliaccio</surname><given-names>E</given-names></name><name><surname>Pelicci</surname><given-names>PG</given-names></name></person-group><article-title>Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals</article-title><source>Nat Rev Mol Cell Biol</source><year>2007</year><volume>8</volume><fpage>722</fpage><lpage>728</lpage><pub-id pub-id-type="pmid">17700625</pub-id></mixed-citation></ref><ref id="bib18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paravicini</surname><given-names>TM</given-names></name><name><surname>Touyz</surname><given-names>RM</given-names></name></person-group><article-title>NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities</article-title><source>Diabetes Care</source><year>2008</year><volume>31</volume><fpage>170</fpage><lpage>180</lpage><pub-id pub-id-type="pmid">17934152</pub-id></mixed-citation></ref><ref id="bib19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lacy</surname><given-names>F</given-names></name><name><surname>Gough</surname><given-names>DA</given-names></name><name><surname>Schmid-Schonbein</surname><given-names>GW</given-names></name></person-group><article-title>Role of xanthine oxidase in hydrogen peroxide production</article-title><source>Free Radic Biol Med</source><year>1998</year><volume>25</volume><fpage>720</fpage><lpage>727</lpage><pub-id pub-id-type="pmid">9801073</pub-id></mixed-citation></ref><ref id="bib20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrew</surname><given-names>PJ</given-names></name><name><surname>Mayer</surname><given-names>B</given-names></name></person-group><article-title>Enzymatic function of nitric oxide synthases</article-title><source>Cardiovasc Res</source><year>1999</year><volume>43</volume><fpage>521</fpage><lpage>531</lpage><pub-id pub-id-type="pmid">10690324</pub-id></mixed-citation></ref><ref id="bib21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schofield</surname><given-names>R</given-names></name></person-group><article-title>The relationship between the spleen colony-forming cell and the haemopoietic stem cell</article-title><source>Blood Cells</source><year>1978</year><volume>4</volume><fpage>7</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">747780</pub-id></mixed-citation></ref><ref id="bib22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scadden</surname><given-names>DT</given-names></name></person-group><article-title>The stem-cell niche as an entity of action</article-title><source>Nature</source><year>2006</year><volume>441</volume><fpage>1075</fpage><lpage>1079</lpage><pub-id pub-id-type="pmid">16810242</pub-id></mixed-citation></ref><ref id="bib23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bianco</surname><given-names>P</given-names></name></person-group><article-title>Bone and the hematopoietic niche: a tale of two stem cells</article-title><source>Blood</source><year>2011</year><volume>117</volume><fpage>5281</fpage><lpage>5288</lpage><pub-id pub-id-type="pmid">21406722</pub-id></mixed-citation></ref><ref id="bib24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohyeldin</surname><given-names>A</given-names></name><name><surname>Garzon-Muvdi</surname><given-names>T</given-names></name><name><surname>Quinones-Hinojosa</surname><given-names>A</given-names></name></person-group><article-title>Oxygen in stem cell biology: a critical component of the stem cell niche</article-title><source>Cell Stem Cell</source><year>2010</year><volume>7</volume><fpage>150</fpage><lpage>161</lpage><pub-id pub-id-type="pmid">20682444</pub-id></mixed-citation></ref><ref id="bib25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katayama</surname><given-names>Y</given-names></name><name><surname>Battista</surname><given-names>M</given-names></name><name><surname>Kao</surname><given-names>WM</given-names></name><name><surname>Hidalgo</surname><given-names>A</given-names></name><name><surname>Peired</surname><given-names>AJ</given-names></name><name><surname>Thomas</surname><given-names>SA</given-names></name><etal/></person-group><article-title>Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow</article-title><source>Cell</source><year>2006</year><volume>124</volume><fpage>407</fpage><lpage>421</lpage><pub-id pub-id-type="pmid">16439213</pub-id></mixed-citation></ref><ref id="bib26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagasawa</surname><given-names>T</given-names></name><name><surname>Omatsu</surname><given-names>Y</given-names></name><name><surname>Sugiyama</surname><given-names>T</given-names></name></person-group><article-title>Control of hematopoietic stem cells by the bone marrow stromal niche: the role of reticular cells</article-title><source>Trends Immunol</source><year>2011</year><volume>32</volume><fpage>315</fpage><lpage>320</lpage><pub-id pub-id-type="pmid">21531624</pub-id></mixed-citation></ref><ref id="bib27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiel</surname><given-names>MJ</given-names></name><name><surname>Morrison</surname><given-names>SJ</given-names></name></person-group><article-title>Uncertainty in the niches that maintain haematopoietic stem cells</article-title><source>Nature</source><year>2008</year><volume>8</volume><fpage>290</fpage><lpage>301</lpage></mixed-citation></ref><ref id="bib28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuchs</surname><given-names>E</given-names></name><name><surname>Tumbar</surname><given-names>T</given-names></name><name><surname>Guasch</surname><given-names>G</given-names></name></person-group><article-title>Socializing with the neighbors: stem cells and their niche</article-title><source>Cell</source><year>2004</year><volume>116</volume><fpage>769</fpage><lpage>778</lpage><pub-id pub-id-type="pmid">15035980</pub-id></mixed-citation></ref><ref id="bib29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Xie</surname><given-names>T</given-names></name></person-group><article-title>Stem cell niche: structure and function</article-title><source>Annu Rev Cell Dev Biol</source><year>2005</year><volume>21</volume><fpage>605</fpage><lpage>631</lpage><pub-id pub-id-type="pmid">16212509</pub-id></mixed-citation></ref><ref id="bib30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arai</surname><given-names>F</given-names></name><name><surname>Hirao</surname><given-names>A</given-names></name><name><surname>Ohmura</surname><given-names>M</given-names></name><name><surname>Sato</surname><given-names>H</given-names></name><name><surname>Matsuoka</surname><given-names>S</given-names></name><name><surname>Takubo</surname><given-names>K</given-names></name><etal/></person-group><article-title>Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche</article-title><source>Cell</source><year>2004</year><volume>118</volume><fpage>149</fpage><lpage>161</lpage><pub-id pub-id-type="pmid">15260986</pub-id></mixed-citation></ref><ref id="bib31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Visnjic</surname><given-names>D</given-names></name><name><surname>Kalajzic</surname><given-names>Z</given-names></name><name><surname>Rowe</surname><given-names>DW</given-names></name><name><surname>Katavic</surname><given-names>V</given-names></name><name><surname>Lorenzo</surname><given-names>J</given-names></name><name><surname>Aguila</surname><given-names>HL</given-names></name></person-group><article-title>Hematopoiesis is severely altered in mice with an induced osteoblast deficiency</article-title><source>Blood</source><year>2004</year><volume>103</volume><fpage>3258</fpage><lpage>3264</lpage><pub-id pub-id-type="pmid">14726388</pub-id></mixed-citation></ref><ref id="bib32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kopp</surname><given-names>HG</given-names></name><name><surname>Avecilla</surname><given-names>ST</given-names></name><name><surname>Hooper</surname><given-names>AT</given-names></name><name><surname>Rafii</surname><given-names>S</given-names></name></person-group><article-title>The bone marrow vascular niche: home of HSC differentiation and mobilization</article-title><source>Physiology</source><year>2005</year><volume>20</volume><fpage>349</fpage><lpage>356</lpage><pub-id pub-id-type="pmid">16174874</pub-id></mixed-citation></ref><ref id="bib33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Johnson</surname><given-names>SA</given-names></name><name><surname>Shelley</surname><given-names>WC</given-names></name><name><surname>Yoder</surname><given-names>MC</given-names></name></person-group><article-title>Hematopoietic stem cell repopulating ability can be maintained <italic>in vitro</italic> by some primary endothelial cells</article-title><source>Exp Hematol</source><year>2004</year><volume>32</volume><fpage>1226</fpage><lpage>1237</lpage><pub-id pub-id-type="pmid">15588947</pub-id></mixed-citation></ref><ref id="bib34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avecilla</surname><given-names>ST</given-names></name><name><surname>Hattori</surname><given-names>K</given-names></name><name><surname>Heissig</surname><given-names>B</given-names></name><name><surname>Tejada</surname><given-names>R</given-names></name><name><surname>Liao</surname><given-names>F</given-names></name><name><surname>Shido</surname><given-names>K</given-names></name><etal/></person-group><article-title>Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis</article-title><source>Nat Med</source><year>2004</year><volume>10</volume><fpage>64</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">14702636</pub-id></mixed-citation></ref><ref id="bib35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chow</surname><given-names>DC</given-names></name><name><surname>Wenning</surname><given-names>LA</given-names></name><name><surname>Miller</surname><given-names>WM</given-names></name><name><surname>Papoutsakis</surname><given-names>ET</given-names></name></person-group><article-title>Modeling pO(2) distributions in the bone marrow hematopoietic compartment. II. Modified Kroghian models</article-title><source>Biophys J</source><year>2001</year><volume>81</volume><fpage>685</fpage><lpage>696</lpage><pub-id pub-id-type="pmid">11463617</pub-id></mixed-citation></ref><ref id="bib36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parmar</surname><given-names>K</given-names></name><name><surname>Mauch</surname><given-names>P</given-names></name><name><surname>Vergilio</surname><given-names>JA</given-names></name><name><surname>Sackstein</surname><given-names>R</given-names></name><name><surname>Down</surname><given-names>JD</given-names></name></person-group><article-title>Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia</article-title><source>Proc Natl Acad Sci USA</source><year>2007</year><volume>104</volume><fpage>5431</fpage><lpage>5436</lpage><pub-id pub-id-type="pmid">17374716</pub-id></mixed-citation></ref><ref id="bib37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hermitte</surname><given-names>F</given-names></name><name><surname>Brunet de la Grange</surname><given-names>P</given-names></name><name><surname>Belloc</surname><given-names>F</given-names></name><name><surname>Praloran</surname><given-names>V</given-names></name><name><surname>Ivanovic</surname><given-names>Z</given-names></name></person-group><article-title>Very low O<sub>2</sub> concentration (0.1&#x00025;) favors G0 return of dividing CD34<sup>&#x0002b;</sup> cells</article-title><source>Stem Cells</source><year>2006</year><volume>24</volume><fpage>65</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">16123391</pub-id></mixed-citation></ref><ref id="bib38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivanovic</surname><given-names>Z</given-names></name><name><surname>Dello Sbarba</surname><given-names>P</given-names></name><name><surname>Trimoreau</surname><given-names>F</given-names></name><name><surname>Faucher</surname><given-names>JL</given-names></name><name><surname>Praloran</surname><given-names>V</given-names></name></person-group><article-title>Primitive human HPCs are better maintained and expanded <italic>in vitro</italic> at 1 percent oxygen than at 20 percent</article-title><source>Transfusion</source><year>2000</year><volume>40</volume><fpage>1482</fpage><lpage>1488</lpage><pub-id pub-id-type="pmid">11134568</pub-id></mixed-citation></ref><ref id="bib39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tauro</surname><given-names>S</given-names></name><name><surname>Hepburn</surname><given-names>MD</given-names></name><name><surname>Bowen</surname><given-names>DT</given-names></name><name><surname>Pippard</surname><given-names>MJ</given-names></name></person-group><article-title>Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes</article-title><source>Haematologica</source><year>2001</year><volume>86</volume><fpage>1038</fpage><lpage>1045</lpage><pub-id pub-id-type="pmid">11602409</pub-id></mixed-citation></ref><ref id="bib40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Gou</surname><given-names>L</given-names></name><name><surname>Xie</surname><given-names>G</given-names></name><name><surname>Tong</surname><given-names>A</given-names></name><name><surname>He</surname><given-names>F</given-names></name><name><surname>Lu</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Proteomic analysis of interstitial fluid in bone marrow identified that peroxiredoxin 2 regulates H(2)O(2) level of bone marrow during aging</article-title><source>J Proteome Res</source><year>2010</year><volume>9</volume><fpage>3812</fpage><lpage>3819</lpage><pub-id pub-id-type="pmid">20568815</pub-id></mixed-citation></ref><ref id="bib41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Unwin</surname><given-names>RD</given-names></name><name><surname>Smith</surname><given-names>DL</given-names></name><name><surname>Blinco</surname><given-names>D</given-names></name><name><surname>Wilson</surname><given-names>CL</given-names></name><name><surname>Miller</surname><given-names>CJ</given-names></name><name><surname>Evans</surname><given-names>CA</given-names></name><etal/></person-group><article-title>Quantitative proteomics reveals posttranslational control as a regulatory factor in primary hematopoietic stem cells</article-title><source>Blood</source><year>2006</year><volume>107</volume><fpage>4687</fpage><lpage>4694</lpage><pub-id pub-id-type="pmid">16507774</pub-id></mixed-citation></ref><ref id="bib42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takubo</surname><given-names>K</given-names></name><name><surname>Goda</surname><given-names>N</given-names></name><name><surname>Yamada</surname><given-names>W</given-names></name><name><surname>Iriuchishima</surname><given-names>H</given-names></name><name><surname>Ikeda</surname><given-names>E</given-names></name><name><surname>Kubota</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Regulation of the HIF-1alpha level is essential for hematopoietic stem cells</article-title><source>Cell Stem Cell</source><year>2010</year><volume>7</volume><fpage>391</fpage><lpage>402</lpage><pub-id pub-id-type="pmid">20804974</pub-id></mixed-citation></ref><ref id="bib43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ceradini</surname><given-names>DJ</given-names></name><name><surname>Kulkarni</surname><given-names>AR</given-names></name><name><surname>Callaghan</surname><given-names>MJ</given-names></name><name><surname>Tepper</surname><given-names>OM</given-names></name><name><surname>Bastidas</surname><given-names>N</given-names></name><name><surname>Kleinman</surname><given-names>ME</given-names></name><etal/></person-group><article-title>Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1</article-title><source>Nat Med</source><year>2004</year><volume>10</volume><fpage>858</fpage><lpage>864</lpage><pub-id pub-id-type="pmid">15235597</pub-id></mixed-citation></ref><ref id="bib44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danet</surname><given-names>GH</given-names></name><name><surname>Pan</surname><given-names>Y</given-names></name><name><surname>Luongo</surname><given-names>JL</given-names></name><name><surname>Bonnet</surname><given-names>DA</given-names></name><name><surname>Simon</surname><given-names>MC</given-names></name></person-group><article-title>Expansion of human SCID-repopulating cells under hypoxic conditions</article-title><source>J Clin Invest</source><year>2003</year><volume>112</volume><fpage>126</fpage><lpage>135</lpage><pub-id pub-id-type="pmid">12840067</pub-id></mixed-citation></ref><ref id="bib45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>S</given-names></name><name><surname>Tripathy</surname><given-names>M</given-names></name><name><surname>Mathur</surname><given-names>N</given-names></name><name><surname>Jain</surname><given-names>A</given-names></name><name><surname>Mukhopadhyay</surname><given-names>A</given-names></name></person-group><article-title>Hypoxia improves expansion potential of human cord blood-derived hematopoietic stem cells and marrow repopulation efficiency</article-title><source>Eur J Haematol</source><year>2012</year><volume>88</volume><fpage>396</fpage><lpage>405</lpage><pub-id pub-id-type="pmid">22268587</pub-id></mixed-citation></ref><ref id="bib46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Honda</surname><given-names>R</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Yasuda</surname><given-names>H</given-names></name></person-group><article-title>Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53</article-title><source>FEBS Lett</source><year>1997</year><volume>420</volume><fpage>25</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">9450543</pub-id></mixed-citation></ref><ref id="bib47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abbas</surname><given-names>HA</given-names></name><name><surname>Maccio</surname><given-names>DR</given-names></name><name><surname>Coskun</surname><given-names>S</given-names></name><name><surname>Jackson</surname><given-names>JG</given-names></name><name><surname>Hazen</surname><given-names>AL</given-names></name><name><surname>Sills</surname><given-names>TM</given-names></name><etal/></person-group><article-title>Mdm2 is required for survival of hematopoietic stem cells/progenitors via dampening of ROS-induced p53 activity</article-title><source>Cell Stem Cell</source><year>2010</year><volume>7</volume><fpage>606</fpage><lpage>617</lpage><pub-id pub-id-type="pmid">21040902</pub-id></mixed-citation></ref><ref id="bib48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakata</surname><given-names>S</given-names></name><name><surname>Matsumura</surname><given-names>I</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Ezoe</surname><given-names>S</given-names></name><name><surname>Satoh</surname><given-names>Y</given-names></name><name><surname>Ishikawa</surname><given-names>J</given-names></name><etal/></person-group><article-title>NF-kB family proteins participate in multiple steps of hematopoiesis through elimination of reactive oxygen species</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><fpage>55578</fpage><lpage>55586</lpage><pub-id pub-id-type="pmid">15485843</pub-id></mixed-citation></ref><ref id="bib49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tothova</surname><given-names>Z</given-names></name><name><surname>Kollipara</surname><given-names>R</given-names></name><name><surname>Huntly</surname><given-names>BJ</given-names></name><name><surname>Lee</surname><given-names>BH</given-names></name><name><surname>Castrillon</surname><given-names>DH</given-names></name><name><surname>Cullen</surname><given-names>DE</given-names></name><etal/></person-group><article-title>FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress</article-title><source>Cell</source><year>2007</year><volume>128</volume><fpage>325</fpage><lpage>339</lpage><pub-id pub-id-type="pmid">17254970</pub-id></mixed-citation></ref><ref id="bib50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yalcin</surname><given-names>S</given-names></name><name><surname>Marinkovic</surname><given-names>D</given-names></name><name><surname>Mungamuri</surname><given-names>SK</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Tong</surname><given-names>W</given-names></name><name><surname>Sellers</surname><given-names>R</given-names></name><etal/></person-group><article-title>ROS-mediated amplification of AKT/mTOR signalling pathway leads to myeloproliferative syndrome in Foxo3(-/-) mice</article-title><source>EMBO J</source><year>2010</year><volume>29</volume><fpage>4118</fpage><lpage>4131</lpage><pub-id pub-id-type="pmid">21113129</pub-id></mixed-citation></ref><ref id="bib51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizo</surname><given-names>A</given-names></name><name><surname>Olthof</surname><given-names>S</given-names></name><name><surname>Han</surname><given-names>L</given-names></name><name><surname>Vellenga</surname><given-names>E</given-names></name><name><surname>de Haan</surname><given-names>G</given-names></name><name><surname>Schuringa</surname><given-names>JJ</given-names></name></person-group><article-title>Repression of BMI1 in normal and leukemic human CD34<sup>&#x0002b;</sup> cells impairs self-renewal and induces apoptosis</article-title><source>Blood</source><year>2009</year><volume>114</volume><fpage>1498</fpage><lpage>1505</lpage><pub-id pub-id-type="pmid">19556423</pub-id></mixed-citation></ref><ref id="bib52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyamoto</surname><given-names>K</given-names></name><name><surname>Araki</surname><given-names>KY</given-names></name><name><surname>Naka</surname><given-names>K</given-names></name><name><surname>Arai</surname><given-names>F</given-names></name><name><surname>Takubo</surname><given-names>K</given-names></name><name><surname>Yamazaki</surname><given-names>S</given-names></name><etal/></person-group><article-title>Foxo3a is essential for maintenance of the hematopoietic stem cell pool</article-title><source>Cell Stem Cell</source><year>2007</year><volume>1</volume><fpage>101</fpage><lpage>112</lpage><pub-id pub-id-type="pmid">18371339</pub-id></mixed-citation></ref><ref id="bib53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jing</surname><given-names>Z</given-names></name><name><surname>Ping</surname><given-names>Z</given-names></name><name><surname>Yi</surname><given-names>L</given-names></name><name><surname>Yin</surname><given-names>X</given-names></name><name><surname>Jie</surname><given-names>W</given-names></name><name><surname>Lingbo</surname><given-names>L</given-names></name></person-group><article-title>The cross-talk between ROS and p38MAPK&#x003b1; in the <italic>ex vivo</italic> expanded human umbilical cord blood CD133<sup>&#x0002b;</sup> cells</article-title><source>J Huazhong Univ Sci Technol</source><year>2011</year><volume>31</volume><fpage>591</fpage><lpage>595</lpage></mixed-citation></ref><ref id="bib54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urao</surname><given-names>N</given-names></name><name><surname>Inomata</surname><given-names>H</given-names></name><name><surname>Razvi</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>HW</given-names></name><name><surname>Wary</surname><given-names>K</given-names></name><name><surname>McKinney</surname><given-names>R</given-names></name><etal/></person-group><article-title>Role of nox2-based NADPH oxidase in bone marrow and progenitor cell function involved in neovascularization induced by hindlimb ischemia</article-title><source>Circ Res</source><year>2008</year><volume>103</volume><fpage>212</fpage><lpage>220</lpage><pub-id pub-id-type="pmid">18583711</pub-id></mixed-citation></ref><ref id="bib55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tesio</surname><given-names>M</given-names></name><name><surname>Golan</surname><given-names>K</given-names></name><name><surname>Corso</surname><given-names>S</given-names></name><name><surname>Giordano</surname><given-names>S</given-names></name><name><surname>Schajnovitz</surname><given-names>A</given-names></name><name><surname>Vagima</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Enhanced c-Met activity promotes G-CSF-induced mobilization of hematopoietic progenitor cells via ROS signaling</article-title><source>Blood</source><year>2011</year><volume>117</volume><fpage>419</fpage><lpage>428</lpage><pub-id pub-id-type="pmid">20585044</pub-id></mixed-citation></ref><ref id="bib56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grek</surname><given-names>CL</given-names></name><name><surname>Townsend</surname><given-names>DM</given-names></name><name><surname>Tew</surname><given-names>KD</given-names></name></person-group><article-title>The impact of redox and thiol status on the bone marrow: pharmacological intervention strategies</article-title><source>Pharmacol Ther</source><year>2011</year><volume>129</volume><fpage>172</fpage><lpage>184</lpage><pub-id pub-id-type="pmid">20951732</pub-id></mixed-citation></ref><ref id="bib57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piccoli</surname><given-names>C</given-names></name><name><surname>Ria</surname><given-names>R</given-names></name><name><surname>Scrima</surname><given-names>R</given-names></name><name><surname>Cela</surname><given-names>O</given-names></name><name><surname>D'Aprile</surname><given-names>A</given-names></name><name><surname>Boffoli</surname><given-names>D</given-names></name><etal/></person-group><article-title>Characterization of mitochondrial and extra-mitochondrial oxygen consuming reactions in human hematopoietic stem cells. Novel evidence of the occurrence of NAD(P)H oxidase activity</article-title><source>J Biol Chem</source><year>2005</year><volume>280</volume><fpage>26467</fpage><lpage>26476</lpage><pub-id pub-id-type="pmid">15883163</pub-id></mixed-citation></ref><ref id="bib58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sardina</surname><given-names>JL</given-names></name><name><surname>Lopez-Ruano</surname><given-names>G</given-names></name><name><surname>Sanchez-Abarca</surname><given-names>LI</given-names></name><name><surname>Perez-Simon</surname><given-names>JA</given-names></name><name><surname>Gaztelumendi</surname><given-names>A</given-names></name><name><surname>Trigueros</surname><given-names>C</given-names></name><etal/></person-group><article-title>p22phox-dependent NADPH oxidase activity is required for megakaryocytic differentiation</article-title><source>Cell Death Differ</source><year>2010</year><volume>17</volume><fpage>1842</fpage><lpage>1854</lpage><pub-id pub-id-type="pmid">20523355</pub-id></mixed-citation></ref><ref id="bib59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mostafa</surname><given-names>SS</given-names></name><name><surname>Miller</surname><given-names>WM</given-names></name><name><surname>Papoutsakis</surname><given-names>ET</given-names></name></person-group><article-title>Oxygen tension influences the differentiation, maturation and apoptosis of human megakaryocytes</article-title><source>Br J Haematol</source><year>2000</year><volume>111</volume><fpage>879</fpage><lpage>889</lpage><pub-id pub-id-type="pmid">11122151</pub-id></mixed-citation></ref><ref id="bib60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCrann</surname><given-names>DJ</given-names></name><name><surname>Eliades</surname><given-names>A</given-names></name><name><surname>Makitalo</surname><given-names>M</given-names></name><name><surname>Matsuno</surname><given-names>K</given-names></name><name><surname>Ravid</surname><given-names>K</given-names></name></person-group><article-title>Differential expression of NADPH oxidases in megakaryocytes and their role in polyploidy</article-title><source>Blood</source><year>2009</year><volume>114</volume><fpage>1243</fpage><lpage>1249</lpage><pub-id pub-id-type="pmid">19471020</pub-id></mixed-citation></ref><ref id="bib61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sattler</surname><given-names>M</given-names></name><name><surname>Winkler</surname><given-names>T</given-names></name><name><surname>Verma</surname><given-names>S</given-names></name><name><surname>Byrne</surname><given-names>CH</given-names></name><name><surname>Shrikhande</surname><given-names>G</given-names></name><name><surname>Salgia</surname><given-names>R</given-names></name><etal/></person-group><article-title>Hematopoietic growth factors signal through the formation of reactive oxygen species</article-title><source>Blood</source><year>1999</year><volume>93</volume><fpage>2928</fpage><lpage>2935</lpage><pub-id pub-id-type="pmid">10216087</pub-id></mixed-citation></ref><ref id="bib62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naughton</surname><given-names>R</given-names></name><name><surname>Quiney</surname><given-names>C</given-names></name><name><surname>Turner</surname><given-names>SD</given-names></name><name><surname>Cotter</surname><given-names>TG</given-names></name></person-group><article-title>Bcr-Abl-mediated redox regulation of the PI3K/AKT pathway</article-title><source>Leukemia</source><year>2009</year><volume>23</volume><fpage>1432</fpage><lpage>1440</lpage><pub-id pub-id-type="pmid">19295548</pub-id></mixed-citation></ref><ref id="bib63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazharian</surname><given-names>A</given-names></name><name><surname>Watson</surname><given-names>SP</given-names></name><name><surname>Severin</surname><given-names>S</given-names></name></person-group><article-title>Critical role for ERK1/2 in bone marrow and fetal liver-derived primary megakaryocyte differentiation, motility, and proplatelet formation</article-title><source>Exp Hematol</source><year>2009</year><volume>37</volume><fpage>1238</fpage><lpage>1249</lpage><pub-id pub-id-type="pmid">19619605</pub-id></mixed-citation></ref><ref id="bib64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruiz-Gines</surname><given-names>JA</given-names></name><name><surname>Lopez-Ongil</surname><given-names>S</given-names></name><name><surname>Gonzalez-Rubio</surname><given-names>M</given-names></name><name><surname>Gonzalez-Santiago</surname><given-names>L</given-names></name><name><surname>Rodriguez-Puyol</surname><given-names>M</given-names></name><name><surname>Rodriguez-Puyol</surname><given-names>D</given-names></name></person-group><article-title>Reactive oxygen species induce proliferation of bovine aortic endothelial cells</article-title><source>J Cardiovasc Pharmacol</source><year>2000</year><volume>35</volume><fpage>109</fpage><lpage>113</lpage><pub-id pub-id-type="pmid">10630740</pub-id></mixed-citation></ref><ref id="bib65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lambeth</surname><given-names>JD</given-names></name></person-group><article-title>NOX enzymes and the biology of reactive oxygen</article-title><source>Nat Rev Immunol</source><year>2004</year><volume>4</volume><fpage>181</fpage><lpage>189</lpage><pub-id pub-id-type="pmid">15039755</pub-id></mixed-citation></ref><ref id="bib66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>del Bello</surname><given-names>B</given-names></name><name><surname>Paolicchi</surname><given-names>A</given-names></name><name><surname>Comporti</surname><given-names>M</given-names></name><name><surname>Pompella</surname><given-names>A</given-names></name><name><surname>Maellaro</surname><given-names>E</given-names></name></person-group><article-title>Hydrogen peroxide produced during gamma-glutamyl transpeptidase activity is involved in prevention of apoptosis and maintainance of proliferation in U937 cells</article-title><source>FASEB J</source><year>1999</year><volume>13</volume><fpage>69</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">9872931</pub-id></mixed-citation></ref><ref id="bib67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griendling</surname><given-names>KK</given-names></name><name><surname>Ushio-Fukai</surname><given-names>M</given-names></name></person-group><article-title>Redox control of vascular smooth muscle proliferation</article-title><source>J Lab Clin Med</source><year>1998</year><volume>132</volume><fpage>9</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">9665366</pub-id></mixed-citation></ref><ref id="bib68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wartenberg</surname><given-names>M</given-names></name><name><surname>Diedershagen</surname><given-names>H</given-names></name><name><surname>Hescheler</surname><given-names>J</given-names></name><name><surname>Sauer</surname><given-names>H</given-names></name></person-group><article-title>Growth stimulation versus induction of cell quiescence by hydrogen peroxide in prostate tumor spheroids is encoded by the duration of the Ca(2&#x0002b;) response</article-title><source>J Biol Chem</source><year>1999</year><volume>274</volume><fpage>27759</fpage><lpage>27767</lpage><pub-id pub-id-type="pmid">10488120</pub-id></mixed-citation></ref><ref id="bib69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Havens</surname><given-names>CG</given-names></name><name><surname>Ho</surname><given-names>A</given-names></name><name><surname>Yoshioka</surname><given-names>N</given-names></name><name><surname>Dowdy</surname><given-names>SF</given-names></name></person-group><article-title>Regulation of late G1/S phase transition and APC Cdh1 by reactive oxygen species</article-title><source>Mol Cell Biol</source><year>2006</year><volume>26</volume><fpage>4701</fpage><lpage>4711</lpage><pub-id pub-id-type="pmid">16738333</pub-id></mixed-citation></ref><ref id="bib70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pallotta</surname><given-names>I</given-names></name><name><surname>Lovett</surname><given-names>M</given-names></name><name><surname>Rice</surname><given-names>W</given-names></name><name><surname>Kaplan</surname><given-names>DL</given-names></name><name><surname>Balduini</surname><given-names>A</given-names></name></person-group><article-title>Bone marrow osteoblastic niche: a new model to study physiological regulation of megakaryopoiesis</article-title><source>PLoS One</source><year>2009</year><volume>4</volume><fpage>e8359</fpage><pub-id pub-id-type="pmid">20027303</pub-id></mixed-citation></ref><ref id="bib71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaushansky</surname><given-names>K</given-names></name></person-group><article-title>The enigmatic megakaryocyte gradually reveals its secrets</article-title><source>Bioessays</source><year>1999</year><volume>21</volume><fpage>353</fpage><lpage>360</lpage><pub-id pub-id-type="pmid">10377897</pub-id></mixed-citation></ref><ref id="bib72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szalai</surname><given-names>G</given-names></name><name><surname>LaRue</surname><given-names>AC</given-names></name><name><surname>Watson</surname><given-names>DK</given-names></name></person-group><article-title>Molecular mechanisms of megakaryopoiesis</article-title><source>Cell Mol Life Sci</source><year>2006</year><volume>63</volume><fpage>2460</fpage><lpage>2476</lpage><pub-id pub-id-type="pmid">16909203</pub-id></mixed-citation></ref><ref id="bib73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xanthoudakis</surname><given-names>S</given-names></name><name><surname>Miao</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Pan</surname><given-names>YC</given-names></name><name><surname>Curran</surname><given-names>T</given-names></name></person-group><article-title>Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme</article-title><source>EMBO J</source><year>1992</year><volume>11</volume><fpage>3323</fpage><lpage>3335</lpage><pub-id pub-id-type="pmid">1380454</pub-id></mixed-citation></ref><ref id="bib74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prata</surname><given-names>C</given-names></name><name><surname>Maraldi</surname><given-names>T</given-names></name><name><surname>Zambonin</surname><given-names>L</given-names></name><name><surname>Fiorentini</surname><given-names>D</given-names></name><name><surname>Hakim</surname><given-names>G</given-names></name><name><surname>Landi</surname><given-names>L</given-names></name></person-group><article-title>ROS production and Glut1 activity in two human megakaryocytic cell lines</article-title><source>Biofactors</source><year>2004</year><volume>20</volume><fpage>223</fpage><lpage>233</lpage><pub-id pub-id-type="pmid">15706059</pub-id></mixed-citation></ref><ref id="bib75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JW</given-names></name><name><surname>Tchernyshyov</surname><given-names>I</given-names></name><name><surname>Semenza</surname><given-names>GL</given-names></name><name><surname>Dang</surname><given-names>CV</given-names></name></person-group><article-title>HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia</article-title><source>Cell Metab</source><year>2006</year><volume>3</volume><fpage>177</fpage><lpage>185</lpage><pub-id pub-id-type="pmid">16517405</pub-id></mixed-citation></ref><ref id="bib76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>K</given-names></name><name><surname>Kirito</surname><given-names>K</given-names></name><name><surname>Yongzhen</surname><given-names>H</given-names></name><name><surname>Ozawa</surname><given-names>K</given-names></name><name><surname>Kaushansky</surname><given-names>K</given-names></name><name><surname>Komatsu</surname><given-names>N</given-names></name></person-group><article-title>Thrombopoietin (TPO) regulates HIF-1alpha levels through generation of mitochondrial reactive oxygen species</article-title><source>Int J Hematol</source><year>2008</year><volume>88</volume><fpage>43</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">18473128</pub-id></mixed-citation></ref><ref id="bib77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LaIuppa</surname><given-names>JA</given-names></name><name><surname>Papoutsakis</surname><given-names>ET</given-names></name><name><surname>Miller</surname><given-names>WM</given-names></name></person-group><article-title>Oxygen tension alters the effects of cytokines on the megakaryocyte, erythrocyte, and granulocyte lineages</article-title><source>Exp Hematol</source><year>1998</year><volume>26</volume><fpage>835</fpage><lpage>843</lpage><pub-id pub-id-type="pmid">9694504</pub-id></mixed-citation></ref><ref id="bib78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCrann</surname><given-names>DJ</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Carroll</surname><given-names>S</given-names></name><name><surname>Ravid</surname><given-names>K</given-names></name></person-group><article-title>Upregulation of Nox4 in the aging vasculature and its association with smooth muscle cell polyploidy</article-title><source>Cell Cycle</source><year>2009</year><volume>8</volume><fpage>902</fpage><lpage>908</lpage><pub-id pub-id-type="pmid">19221493</pub-id></mixed-citation></ref><ref id="bib79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eliades</surname><given-names>A</given-names></name><name><surname>Papadantonakis</surname><given-names>N</given-names></name><name><surname>Ravid</surname><given-names>K</given-names></name></person-group><article-title>New roles for cyclin E in megakaryocytic polyploidization</article-title><source>J Biol Chem</source><year>2010</year><volume>285</volume><fpage>18909</fpage><lpage>18917</lpage><pub-id pub-id-type="pmid">20392692</pub-id></mixed-citation></ref><ref id="bib80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>S</given-names></name><name><surname>Ravid</surname><given-names>K</given-names></name></person-group><article-title>Mpl ligand enhances the transcription of the cyclin D3 gene: a potential role for Sp1 transcription factor</article-title><source>Blood</source><year>1999</year><volume>93</volume><fpage>4208</fpage><lpage>4221</lpage><pub-id pub-id-type="pmid">10361118</pub-id></mixed-citation></ref><ref id="bib81"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Sicinski</surname><given-names>P</given-names></name><name><surname>Weinberg</surname><given-names>RA</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Ravid</surname><given-names>K</given-names></name></person-group><article-title>Characterization of the mouse cyclin D3 gene: exon/intron organization and promoter activity</article-title><source>Genomics</source><year>1996</year><volume>35</volume><fpage>156</fpage><lpage>163</lpage><pub-id pub-id-type="pmid">8661116</pub-id></mixed-citation></ref><ref id="bib82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia</surname><given-names>P</given-names></name><name><surname>Frampton</surname><given-names>J</given-names></name><name><surname>Ballester</surname><given-names>A</given-names></name><name><surname>Cales</surname><given-names>C</given-names></name></person-group><article-title>Ectopic expression of cyclin E allows non-endomitotic megakaryoblastic K562 cells to establish re-replication cycles</article-title><source>Oncogene</source><year>2000</year><volume>19</volume><fpage>1820</fpage><lpage>1833</lpage><pub-id pub-id-type="pmid">10777216</pub-id></mixed-citation></ref><ref id="bib83"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Junt</surname><given-names>T</given-names></name><name><surname>Schulze</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Massberg</surname><given-names>S</given-names></name><name><surname>Goerge</surname><given-names>T</given-names></name><name><surname>Krueger</surname><given-names>A</given-names></name><etal/></person-group><article-title>Dynamic visualization of thrombopoiesis within bone marrow</article-title><source>Science</source><year>2007</year><volume>317</volume><fpage>1767</fpage><lpage>1770</lpage><pub-id pub-id-type="pmid">17885137</pub-id></mixed-citation></ref><ref id="bib84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Brien</surname><given-names>JJ</given-names></name><name><surname>Spinelli</surname><given-names>SL</given-names></name><name><surname>Tober</surname><given-names>J</given-names></name><name><surname>Blumberg</surname><given-names>N</given-names></name><name><surname>Francis</surname><given-names>CW</given-names></name><name><surname>Taubman</surname><given-names>MB</given-names></name><etal/></person-group><article-title>15-Deoxy-&#x00394;12,14-PGJ2 enhances platelet production from megakaryocytes</article-title><source>Blood</source><year>2008</year><volume>112</volume><fpage>4051</fpage><lpage>4060</lpage><pub-id pub-id-type="pmid">18755987</pub-id></mixed-citation></ref><ref id="bib85"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mostafa</surname><given-names>SS</given-names></name><name><surname>Papoutsakis</surname><given-names>ET</given-names></name><name><surname>Miller</surname><given-names>WM</given-names></name></person-group><article-title>Oxygen tension modulates the expression of cytokine receptors, transcription factors, and lineage-specific markers in cultured human megakaryocytes</article-title><source>Exp Hematol</source><year>2001</year><volume>29</volume><fpage>873</fpage><lpage>883</lpage><pub-id pub-id-type="pmid">11438210</pub-id></mixed-citation></ref><ref id="bib86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehaffey</surname><given-names>MG</given-names></name><name><surname>Newton</surname><given-names>AL</given-names></name><name><surname>Gandhi</surname><given-names>MJ</given-names></name><name><surname>Crossley</surname><given-names>M</given-names></name><name><surname>Drachman</surname><given-names>JG</given-names></name></person-group><article-title>X-linked thrombocytopenia caused by a novel mutation of GATA-1</article-title><source>Blood</source><year>2001</year><volume>98</volume><fpage>2681</fpage><lpage>2688</lpage><pub-id pub-id-type="pmid">11675338</pub-id></mixed-citation></ref><ref id="bib87"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lecine</surname><given-names>P</given-names></name><name><surname>Villeval</surname><given-names>JL</given-names></name><name><surname>Vyas</surname><given-names>P</given-names></name><name><surname>Swencki</surname><given-names>B</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Shivdasani</surname><given-names>RA</given-names></name></person-group><article-title>Mice lacking transcription factor NF-E2 provide <italic>in vivo</italic> validation of the proplatelet model of thrombocytopoiesis and show a platelet production defect that is intrinsic to megakaryocytes</article-title><source>Blood</source><year>1998</year><volume>92</volume><fpage>1608</fpage><lpage>1616</lpage><pub-id pub-id-type="pmid">9716588</pub-id></mixed-citation></ref><ref id="bib88"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Battinelli</surname><given-names>E</given-names></name><name><surname>Loscalzo</surname><given-names>J</given-names></name></person-group><article-title>Nitric oxide induces apoptosis in megakaryocytic cell lines</article-title><source>Blood</source><year>2000</year><volume>95</volume><fpage>3451</fpage><lpage>3459</lpage><pub-id pub-id-type="pmid">10828028</pub-id></mixed-citation></ref><ref id="bib89"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Battinelli</surname><given-names>E</given-names></name><name><surname>Willoughby</surname><given-names>SR</given-names></name><name><surname>Foxall</surname><given-names>T</given-names></name><name><surname>Valeri</surname><given-names>CR</given-names></name><name><surname>Loscalzo</surname><given-names>J</given-names></name></person-group><article-title>Induction of platelet formation from megakaryocytoid cells by nitric oxide</article-title><source>Proc Natl Acad Sci USA</source><year>2001</year><volume>98</volume><fpage>14458</fpage><lpage>14463</lpage><pub-id pub-id-type="pmid">11734646</pub-id></mixed-citation></ref><ref id="bib90"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freedman</surname><given-names>JE</given-names></name><name><surname>Loscalzo</surname><given-names>J</given-names></name><name><surname>Barnard</surname><given-names>MR</given-names></name><name><surname>Alpert</surname><given-names>C</given-names></name><name><surname>Keaney</surname><given-names>JF</given-names></name><name><surname>Michelson</surname><given-names>AD</given-names></name></person-group><article-title>Nitric oxide released from activated platelets inhibits platelet recruitment</article-title><source>J Clin Invest</source><year>1997</year><volume>100</volume><fpage>350</fpage><lpage>356</lpage><pub-id pub-id-type="pmid">9218511</pub-id></mixed-citation></ref><ref id="bib91"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>YZ</given-names></name><name><surname>Kagan</surname><given-names>E</given-names></name><name><surname>Bonner</surname><given-names>JC</given-names></name></person-group><article-title>Peroxynitrite targets the epidermal growth factor receptor, Raf-1, and MEK independently to activate MAPK</article-title><source>J Biol Chem</source><year>2000</year><volume>275</volume><fpage>22479</fpage><lpage>22486</lpage><pub-id pub-id-type="pmid">10801894</pub-id></mixed-citation></ref><ref id="bib92"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Motohashi</surname><given-names>H</given-names></name><name><surname>Katsuoka</surname><given-names>F</given-names></name><name><surname>Engel</surname><given-names>JD</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name></person-group><article-title>Small Maf proteins serve as transcriptional cofactors for keratinocyte differentiation in the Keap1-Nrf2 regulatory pathway</article-title><source>Proc Natl Acad Sci USA</source><year>2004</year><volume>101</volume><fpage>6379</fpage><lpage>6384</lpage><pub-id pub-id-type="pmid">15087497</pub-id></mixed-citation></ref><ref id="bib93"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Itoh</surname><given-names>K</given-names></name><name><surname>Chiba</surname><given-names>T</given-names></name><name><surname>Takahashi</surname><given-names>S</given-names></name><name><surname>Ishii</surname><given-names>T</given-names></name><name><surname>Igarashi</surname><given-names>K</given-names></name><name><surname>Katoh</surname><given-names>Y</given-names></name><etal/></person-group><article-title>An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements</article-title><source>Biochem Biophys Res Commun</source><year>1997</year><volume>236</volume><fpage>313</fpage><lpage>322</lpage><pub-id pub-id-type="pmid">9240432</pub-id></mixed-citation></ref><ref id="bib94"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katsuoka</surname><given-names>F</given-names></name><name><surname>Motohashi</surname><given-names>H</given-names></name><name><surname>Ishii</surname><given-names>T</given-names></name><name><surname>Aburatani</surname><given-names>H</given-names></name><name><surname>Engel</surname><given-names>JD</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name></person-group><article-title>Genetic evidence that small maf proteins are essential for the activation of antioxidant response element-dependent genes</article-title><source>Mol Cell Biol</source><year>2005</year><volume>25</volume><fpage>8044</fpage><lpage>8051</lpage><pub-id pub-id-type="pmid">16135796</pub-id></mixed-citation></ref><ref id="bib95"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Hu</surname><given-names>M</given-names></name><name><surname>Shivdasani</surname><given-names>RA</given-names></name></person-group><article-title>Expression analysis of primary mouse megakaryocyte differentiation and its application in identifying stage-specific molecular markers and a novel transcriptional target of NF-E2</article-title><source>Blood</source><year>2007</year><volume>109</volume><fpage>1451</fpage><lpage>1459</lpage><pub-id pub-id-type="pmid">17047147</pub-id></mixed-citation></ref><ref id="bib96"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Igarashi</surname><given-names>K</given-names></name><name><surname>Kataoka</surname><given-names>K</given-names></name><name><surname>Itoh</surname><given-names>K</given-names></name><name><surname>Hayashi</surname><given-names>N</given-names></name><name><surname>Nishizawa</surname><given-names>M</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name></person-group><article-title>Regulation of transcription by dimerization of erythroid factor NF-E2 p45 with small Maf proteins</article-title><source>Nature</source><year>1994</year><volume>367</volume><fpage>568</fpage><lpage>572</lpage><pub-id pub-id-type="pmid">8107826</pub-id></mixed-citation></ref><ref id="bib97"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Motohashi</surname><given-names>H</given-names></name><name><surname>Katsuoka</surname><given-names>F</given-names></name><name><surname>Shavit</surname><given-names>JA</given-names></name><name><surname>Engel</surname><given-names>JD</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name></person-group><article-title>Positive or negative MARE-dependent transcriptional regulation is determined by the abundance of small Maf proteins</article-title><source>Cell</source><year>2000</year><volume>103</volume><fpage>865</fpage><lpage>875</lpage><pub-id pub-id-type="pmid">11136972</pub-id></mixed-citation></ref><ref id="bib98"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Motohashi</surname><given-names>H</given-names></name><name><surname>Kimura</surname><given-names>M</given-names></name><name><surname>Fujita</surname><given-names>R</given-names></name><name><surname>Inoue</surname><given-names>A</given-names></name><name><surname>Pan</surname><given-names>X</given-names></name><name><surname>Takayama</surname><given-names>M</given-names></name><etal/></person-group><article-title>NF-E2 domination over Nrf2 promotes ROS accumulation and megakaryocytic maturation</article-title><source>Blood</source><year>2010</year><volume>115</volume><fpage>677</fpage><lpage>686</lpage><pub-id pub-id-type="pmid">19901266</pub-id></mixed-citation></ref><ref id="bib99"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blair</surname><given-names>P</given-names></name><name><surname>Rex</surname><given-names>S</given-names></name><name><surname>Vitseva</surname><given-names>O</given-names></name><name><surname>Beaulieu</surname><given-names>L</given-names></name><name><surname>Tanriverdi</surname><given-names>K</given-names></name><name><surname>Chakrabarti</surname><given-names>S</given-names></name><etal/></person-group><article-title>Stimulation of Toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase</article-title><source>Circ Res</source><year>2009</year><volume>104</volume><fpage>346</fpage><lpage>354</lpage><pub-id pub-id-type="pmid">19106411</pub-id></mixed-citation></ref><ref id="bib100"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beaulieu</surname><given-names>LM</given-names></name><name><surname>Lin</surname><given-names>E</given-names></name><name><surname>Morin</surname><given-names>KM</given-names></name><name><surname>Tanriverdi</surname><given-names>K</given-names></name><name><surname>Freedman</surname><given-names>JE</given-names></name></person-group><article-title>Regulatory effects of TLR2 on megakaryocytic cell function</article-title><source>Blood</source><year>2011</year><volume>117</volume><fpage>5963</fpage><lpage>5974</lpage><pub-id pub-id-type="pmid">21454454</pub-id></mixed-citation></ref><ref id="bib101"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ray</surname><given-names>DM</given-names></name><name><surname>Akbiyik</surname><given-names>F</given-names></name><name><surname>Phipps</surname><given-names>RP</given-names></name></person-group><article-title>The peroxisome proliferator-activated receptor gamma (PPARgamma) ligands 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone induce human B lymphocyte and B cell lymphoma apoptosis by PPARgamma-independent mechanisms</article-title><source>J Immunol</source><year>2006</year><volume>177</volume><fpage>5068</fpage><lpage>5076</lpage><pub-id pub-id-type="pmid">17015690</pub-id></mixed-citation></ref><ref id="bib102"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siddiqui</surname><given-names>NF</given-names></name><name><surname>Shabrani</surname><given-names>NC</given-names></name><name><surname>Kale</surname><given-names>VP</given-names></name><name><surname>Limaye</surname><given-names>LS</given-names></name></person-group><article-title>Enhanced generation of megakaryocytes from umbilical cord blood-derived CD34(&#x0002b;) cells expanded in the presence of two nutraceuticals, docosahexanoic acid and arachidonic acid, as supplements to the cytokine-containing medium</article-title><source>Cytotherapy</source><year>2011</year><volume>13</volume><fpage>114</fpage><lpage>128</lpage><pub-id pub-id-type="pmid">20230224</pub-id></mixed-citation></ref><ref id="bib103"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>WQ</given-names></name><name><surname>Zhang</surname><given-names>HF</given-names></name><name><surname>Gao</surname><given-names>GX</given-names></name><name><surname>Bai</surname><given-names>QX</given-names></name><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>XM</given-names></name></person-group><article-title>Adiponectin inhibits hyperlipidemia-induced platelet aggregation via attenuating oxidative/nitrative stress</article-title><source>Physiol Res</source><year>2011</year><volume>60</volume><fpage>347</fpage><lpage>354</lpage><pub-id pub-id-type="pmid">21114366</pub-id></mixed-citation></ref><ref id="bib104"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iuliano</surname><given-names>L</given-names></name><name><surname>Pratico</surname><given-names>D</given-names></name><name><surname>Ghiselli</surname><given-names>A</given-names></name><name><surname>Bonavita</surname><given-names>MS</given-names></name><name><surname>Violi</surname><given-names>F</given-names></name></person-group><article-title>Superoxide dismutase triggers activation of &#x02018;primed' platelets</article-title><source>Arch Biochem Biophys</source><year>1991</year><volume>289</volume><fpage>180</fpage><lpage>183</lpage><pub-id pub-id-type="pmid">1910314</pub-id></mixed-citation></ref><ref id="bib105"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Handin</surname><given-names>RI</given-names></name><name><surname>Karabin</surname><given-names>R</given-names></name><name><surname>Boxer</surname><given-names>GJ</given-names></name></person-group><article-title>Enhancement of platelet function by superoxide anion</article-title><source>J Clin Invest</source><year>1977</year><volume>59</volume><fpage>959</fpage><lpage>965</lpage><pub-id pub-id-type="pmid">192766</pub-id></mixed-citation></ref><ref id="bib106"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ambrosio</surname><given-names>G</given-names></name><name><surname>Golino</surname><given-names>P</given-names></name><name><surname>Pascucci</surname><given-names>I</given-names></name><name><surname>Rosolowsky</surname><given-names>M</given-names></name><name><surname>Campbell</surname><given-names>WB</given-names></name><name><surname>DeClerck</surname><given-names>F</given-names></name><etal/></person-group><article-title>Modulation of platelet function by reactive oxygen metabolites</article-title><source>Am J Physiol</source><year>1994</year><volume>267</volume><fpage>H308</fpage><lpage>H318</lpage><pub-id pub-id-type="pmid">8048596</pub-id></mixed-citation></ref><ref id="bib107"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Del Principe</surname><given-names>D</given-names></name><name><surname>Menichelli</surname><given-names>A</given-names></name><name><surname>De Matteis</surname><given-names>W</given-names></name><name><surname>Di Corpo</surname><given-names>ML</given-names></name><name><surname>Di Giulio</surname><given-names>S</given-names></name><name><surname>Finazzi-Agro</surname><given-names>A</given-names></name></person-group><article-title>Hydrogen peroxide has a role in the aggregation of human platelets</article-title><source>FEBS Lett</source><year>1985</year><volume>185</volume><fpage>142</fpage><lpage>146</lpage><pub-id pub-id-type="pmid">3996592</pub-id></mixed-citation></ref><ref id="bib108"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pignatelli</surname><given-names>P</given-names></name><name><surname>Pulcinelli</surname><given-names>FM</given-names></name><name><surname>Lenti</surname><given-names>L</given-names></name><name><surname>Gazzaniga</surname><given-names>PP</given-names></name><name><surname>Violi</surname><given-names>F</given-names></name><name><surname>Pignatelli</surname><given-names>BP</given-names></name></person-group><article-title>Hydrogen peroxide is involved in collagen-induced platelet activation</article-title><source>Blood</source><year>1998</year><volume>91</volume><fpage>484</fpage><lpage>490</lpage><pub-id pub-id-type="pmid">9427701</pub-id></mixed-citation></ref><ref id="bib109"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seno</surname><given-names>T</given-names></name><name><surname>Inoue</surname><given-names>N</given-names></name><name><surname>Gao</surname><given-names>D</given-names></name><name><surname>Okuda</surname><given-names>M</given-names></name><name><surname>Sumi</surname><given-names>Y</given-names></name><name><surname>Matsui</surname><given-names>K</given-names></name><etal/></person-group><article-title>Involvement of NADH/NADPH oxidase in human platelet ROS production</article-title><source>Thromb Res</source><year>2001</year><volume>103</volume><fpage>399</fpage><lpage>409</lpage><pub-id pub-id-type="pmid">11553372</pub-id></mixed-citation></ref><ref id="bib110"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savini</surname><given-names>I</given-names></name><name><surname>Arnone</surname><given-names>R</given-names></name><name><surname>Rossi</surname><given-names>A</given-names></name><name><surname>Catani</surname><given-names>MV</given-names></name><name><surname>Del Principe</surname><given-names>D</given-names></name><name><surname>Avigliano</surname><given-names>L</given-names></name></person-group><article-title>Redox modulation of Ecto-NOX1 in human platelets</article-title><source>Mol Membr Biol</source><year>2010</year><volume>27</volume><fpage>160</fpage><lpage>169</lpage><pub-id pub-id-type="pmid">20462348</pub-id></mixed-citation></ref><ref id="bib111"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schafer</surname><given-names>A</given-names></name><name><surname>Wiesmann</surname><given-names>F</given-names></name><name><surname>Neubauer</surname><given-names>S</given-names></name><name><surname>Eigenthaler</surname><given-names>M</given-names></name><name><surname>Bauersachs</surname><given-names>J</given-names></name><name><surname>Channon</surname><given-names>KM</given-names></name></person-group><article-title>Rapid regulation of platelet activation <italic>in vivo</italic> by nitric oxide</article-title><source>Circulation</source><year>2004</year><volume>109</volume><fpage>1819</fpage><lpage>1822</lpage><pub-id pub-id-type="pmid">15066953</pub-id></mixed-citation></ref><ref id="bib112"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clutton</surname><given-names>P</given-names></name><name><surname>Miermont</surname><given-names>A</given-names></name><name><surname>Freedman</surname><given-names>JE</given-names></name></person-group><article-title>Regulation of endogenous reactive oxygen species in platelets can reverse aggregation</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2004</year><volume>24</volume><fpage>187</fpage><lpage>192</lpage><pub-id pub-id-type="pmid">14604832</pub-id></mixed-citation></ref><ref id="bib113"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferroni</surname><given-names>P</given-names></name><name><surname>Vazzana</surname><given-names>N</given-names></name><name><surname>Riondino</surname><given-names>S</given-names></name><name><surname>Cuccurullo</surname><given-names>C</given-names></name><name><surname>Guadagni</surname><given-names>F</given-names></name><name><surname>Davi</surname><given-names>G</given-names></name></person-group><article-title>Platelet function in health and disease: from molecular mechanisms, redox considerations to novel therapeutic opportunities</article-title><source>Antioxid Redox Signal</source><year>2012</year><volume>17</volume><fpage>1447</fpage><lpage>1485</lpage><pub-id pub-id-type="pmid">22458931</pub-id></mixed-citation></ref><ref id="bib114"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schildknecht</surname><given-names>S</given-names></name><name><surname>van der Loo</surname><given-names>B</given-names></name><name><surname>Weber</surname><given-names>K</given-names></name><name><surname>Tiefenthaler</surname><given-names>K</given-names></name><name><surname>Daiber</surname><given-names>A</given-names></name><name><surname>Bachschmid</surname><given-names>MM</given-names></name></person-group><article-title>Endogenous peroxynitrite modulates PGHS-1-dependent thromboxane A2 formation and aggregation in human platelets</article-title><source>Free Radic Biol Med</source><year>2008</year><volume>45</volume><fpage>512</fpage><lpage>520</lpage><pub-id pub-id-type="pmid">18514074</pub-id></mixed-citation></ref><ref id="bib115"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krotz</surname><given-names>F</given-names></name><name><surname>Sohn</surname><given-names>HY</given-names></name><name><surname>Gloe</surname><given-names>T</given-names></name><name><surname>Zahler</surname><given-names>S</given-names></name><name><surname>Riexinger</surname><given-names>T</given-names></name><name><surname>Schiele</surname><given-names>TM</given-names></name><etal/></person-group><article-title>NAD(P)H oxidase-dependent platelet superoxide anion release increases platelet recruitment</article-title><source>Blood</source><year>2002</year><volume>100</volume><fpage>917</fpage><lpage>924</lpage><pub-id pub-id-type="pmid">12130503</pub-id></mixed-citation></ref><ref id="bib116"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Begonja</surname><given-names>AJ</given-names></name></person-group><source>NO/cGMP and ROS pathways in regulation of platelet function and megakaryocyte maturation</source><publisher-name>Disertation, Julius-Maximilians University: Wurzburg</publisher-name><year>2007</year></mixed-citation></ref><ref id="bib117"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krotz</surname><given-names>F</given-names></name><name><surname>Sohn</surname><given-names>HY</given-names></name><name><surname>Pohl</surname><given-names>U</given-names></name></person-group><article-title>Reactive oxygen species: players in the platelet game</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2004</year><volume>24</volume><fpage>1988</fpage><lpage>1996</lpage><pub-id pub-id-type="pmid">15374851</pub-id></mixed-citation></ref><ref id="bib118"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Brien</surname><given-names>JJ</given-names></name><name><surname>Baglole</surname><given-names>CJ</given-names></name><name><surname>Garcia-Bates</surname><given-names>TM</given-names></name><name><surname>Blumberg</surname><given-names>N</given-names></name><name><surname>Francis</surname><given-names>CW</given-names></name><name><surname>Phipps</surname><given-names>RP</given-names></name></person-group><article-title>15-Deoxy-Delta12,14 prostaglandin J2-induced heme oxygenase-1 in megakaryocytes regulates thrombopoiesis</article-title><source>J Thromb Haemost</source><year>2009</year><volume>7</volume><fpage>182</fpage><lpage>189</lpage><pub-id pub-id-type="pmid">18983509</pub-id></mixed-citation></ref><ref id="bib119"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Cang</surname><given-names>H</given-names></name><name><surname>Shi</surname><given-names>G</given-names></name><name><surname>Yi</surname><given-names>J</given-names></name></person-group><article-title>NADPH oxidase-derived reactive oxygen species are responsible for the high susceptibility to arsenic cytotoxicity in acute promyelocytic leukemia cells</article-title><source>Leuk Res</source><year>2008</year><volume>32</volume><fpage>429</fpage><lpage>436</lpage><pub-id pub-id-type="pmid">17804067</pub-id></mixed-citation></ref><ref id="bib120"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Chew</surname><given-names>EH</given-names></name><name><surname>Holmgren</surname><given-names>A</given-names></name></person-group><article-title>Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide</article-title><source>Proc Natl Acad Sci USA</source><year>2007</year><volume>104</volume><fpage>12288</fpage><lpage>12293</lpage><pub-id pub-id-type="pmid">17640917</pub-id></mixed-citation></ref><ref id="bib121"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peeters</surname><given-names>K</given-names></name><name><surname>Stassen</surname><given-names>JM</given-names></name><name><surname>Collen</surname><given-names>D</given-names></name><name><surname>Van Geet</surname><given-names>C</given-names></name><name><surname>Freson</surname><given-names>K</given-names></name></person-group><article-title>Emerging treatments for thrombocytopenia: increasing platelet production</article-title><source>Drug Discov Today</source><year>2008</year><volume>13</volume><fpage>798</fpage><lpage>806</lpage><pub-id pub-id-type="pmid">18602017</pub-id></mixed-citation></ref><ref id="bib122"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivera</surname><given-names>J</given-names></name><name><surname>Lozano</surname><given-names>ML</given-names></name><name><surname>Navarro-Nunez</surname><given-names>L</given-names></name><name><surname>Vicente</surname><given-names>V</given-names></name></person-group><article-title>Platelet receptors and signaling in the dynamics of thrombus formation</article-title><source>Haematologica</source><year>2009</year><volume>94</volume><fpage>700</fpage><lpage>711</lpage><pub-id pub-id-type="pmid">19286885</pub-id></mixed-citation></ref><ref id="bib123"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pleines</surname><given-names>I</given-names></name><name><surname>Hagedorn</surname><given-names>I</given-names></name><name><surname>Gupta</surname><given-names>S</given-names></name><name><surname>May</surname><given-names>F</given-names></name><name><surname>Chakarova</surname><given-names>L</given-names></name><name><surname>van Hengel</surname><given-names>J</given-names></name><etal/></person-group><article-title>Megakaryocyte-specific RhoA deficiency causes macrothrombocytopenia and defective platelet activation in hemostasis and thrombosis</article-title><source>Blood</source><year>2012</year><volume>119</volume><fpage>1054</fpage><lpage>1063</lpage><pub-id pub-id-type="pmid">22045984</pub-id></mixed-citation></ref><ref id="bib124"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antoniades</surname><given-names>C</given-names></name><name><surname>Bakogiannis</surname><given-names>C</given-names></name><name><surname>Tousoulis</surname><given-names>D</given-names></name><name><surname>Demosthenous</surname><given-names>M</given-names></name><name><surname>Marinou</surname><given-names>K</given-names></name><name><surname>Stefanadis</surname><given-names>C</given-names></name></person-group><article-title>Platelet activation in atherogenesis associated with low-grade inflammation</article-title><source>Inflamm Allergy Drug Targets</source><year>2010</year><volume>9</volume><fpage>334</fpage><lpage>345</lpage><pub-id pub-id-type="pmid">20632958</pub-id></mixed-citation></ref><ref id="bib125"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monteiro</surname><given-names>PF</given-names></name><name><surname>Morganti</surname><given-names>RP</given-names></name><name><surname>Delbin</surname><given-names>MA</given-names></name><name><surname>Calixto</surname><given-names>MC</given-names></name><name><surname>Lopes-Pires</surname><given-names>ME</given-names></name><name><surname>Marcondes</surname><given-names>S</given-names></name><etal/></person-group><article-title>Platelet hyperaggregability in high-fat fed rats: a role for intraplatelet reactive-oxygen species production</article-title><source>Cardiovasc Diabetol</source><year>2012</year><volume>11</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">22230104</pub-id></mixed-citation></ref><ref id="bib126"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lakshmi</surname><given-names>SV</given-names></name><name><surname>Padmaja</surname><given-names>G</given-names></name><name><surname>Kuppusamy</surname><given-names>P</given-names></name><name><surname>Kutala</surname><given-names>VK</given-names></name></person-group><article-title>Oxidative stress in cardiovascular disease</article-title><source>Indian J Biochem Biophys</source><year>2009</year><volume>46</volume><fpage>421</fpage><lpage>440</lpage><pub-id pub-id-type="pmid">20361706</pub-id></mixed-citation></ref><ref id="bib127"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhalla</surname><given-names>NS</given-names></name><name><surname>Temsah</surname><given-names>RM</given-names></name><name><surname>Netticadan</surname><given-names>T</given-names></name></person-group><article-title>Role of oxidative stress in cardiovascular diseases</article-title><source>J Hypertens</source><year>2000</year><volume>18</volume><fpage>655</fpage><lpage>673</lpage><pub-id pub-id-type="pmid">10872549</pub-id></mixed-citation></ref><ref id="bib128"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>N</given-names></name><name><surname>Andresen</surname><given-names>BT</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name></person-group><article-title>Inflammation and reactive oxygen species in cardiovascular disease</article-title><source>World J Cardiol</source><year>2010</year><volume>2</volume><fpage>408</fpage><lpage>410</lpage><pub-id pub-id-type="pmid">21191541</pub-id></mixed-citation></ref><ref id="bib129"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bae</surname><given-names>JS</given-names></name></person-group><article-title>Antithrombotic and profibrinolytic activities of phloroglucinol</article-title><source>Food Chem Toxicol</source><year>2011</year><volume>49</volume><fpage>1572</fpage><lpage>1577</lpage><pub-id pub-id-type="pmid">21501649</pub-id></mixed-citation></ref><ref id="bib130"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Qian</surname><given-names>ZJ</given-names></name><name><surname>Ryu</surname><given-names>B</given-names></name><name><surname>Lee</surname><given-names>SH</given-names></name><name><surname>Kim</surname><given-names>MM</given-names></name><name><surname>Kim</surname><given-names>SK</given-names></name></person-group><article-title>Chemical components and its antioxidant properties <italic>in vitro</italic>: an edible marine brown alga, <italic>Ecklonia cava</italic></article-title><source>Bioorg Med Chem</source><year>2009</year><volume>17</volume><fpage>1963</fpage><lpage>1973</lpage><pub-id pub-id-type="pmid">19201199</pub-id></mixed-citation></ref><ref id="bib131"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>MC</given-names></name><name><surname>Chang</surname><given-names>HH</given-names></name><name><surname>Chan</surname><given-names>CP</given-names></name><name><surname>Chou</surname><given-names>HY</given-names></name><name><surname>Chang</surname><given-names>BE</given-names></name><name><surname>Yeung</surname><given-names>SY</given-names></name><etal/></person-group><article-title>Antiplatelet effect of phloroglucinol is related to inhibition of cyclooxygenase, reactive oxygen species, ERK/p38 signaling and thromboxane A2 production</article-title><source>Toxicol Appl Pharmacol</source><year>2012</year><volume>263</volume><fpage>287</fpage><lpage>295</lpage><pub-id pub-id-type="pmid">22789837</pub-id></mixed-citation></ref><ref id="bib132"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fassett</surname><given-names>RG</given-names></name><name><surname>Coombes</surname><given-names>JS</given-names></name></person-group><article-title>Astaxanthin: a potential therapeutic agent in cardiovascular disease</article-title><source>Mar Drugs</source><year>2011</year><volume>9</volume><fpage>447</fpage><lpage>465</lpage><pub-id pub-id-type="pmid">21556169</pub-id></mixed-citation></ref><ref id="bib133"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>H</given-names></name></person-group><article-title>Hydrogen peroxide regulation of endothelial function: origins, mechanisms, and consequences</article-title><source>Cardiovasc Res</source><year>2005</year><volume>68</volume><fpage>26</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">16009356</pub-id></mixed-citation></ref><ref id="bib134"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stolk</surname><given-names>J</given-names></name><name><surname>Hiltermann</surname><given-names>TJ</given-names></name><name><surname>Dijkman</surname><given-names>JH</given-names></name><name><surname>Verhoeven</surname><given-names>AJ</given-names></name></person-group><article-title>Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol</article-title><source>Am J Respir Cell Mol Biol</source><year>1994</year><volume>11</volume><fpage>95</fpage><lpage>102</lpage><pub-id pub-id-type="pmid">8018341</pub-id></mixed-citation></ref><ref id="bib135"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>H</given-names></name><name><surname>Griendling</surname><given-names>KK</given-names></name><name><surname>Harrison</surname><given-names>DG</given-names></name></person-group><article-title>The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases</article-title><source>Trends Pharmacol Sci</source><year>2003</year><volume>24</volume><fpage>471</fpage><lpage>478</lpage><pub-id pub-id-type="pmid">12967772</pub-id></mixed-citation></ref><ref id="bib136"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diatchuk</surname><given-names>V</given-names></name><name><surname>Lotan</surname><given-names>O</given-names></name><name><surname>Koshkin</surname><given-names>V</given-names></name><name><surname>Wikstroem</surname><given-names>P</given-names></name><name><surname>Pick</surname><given-names>E</given-names></name></person-group><article-title>Inhibition of NADPH oxidase activation by 4-(2-aminoethyl)-benzenesulfonyl fluoride and related compounds</article-title><source>J Biol Chem</source><year>1997</year><volume>272</volume><fpage>13292</fpage><lpage>13301</lpage><pub-id pub-id-type="pmid">9148950</pub-id></mixed-citation></ref><ref id="bib137"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drummond</surname><given-names>GR</given-names></name><name><surname>Selemidis</surname><given-names>S</given-names></name><name><surname>Griendling</surname><given-names>KK</given-names></name><name><surname>Sobey</surname><given-names>CG</given-names></name></person-group><article-title>Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets</article-title><source>Nat Rev Drug Discov</source><year>2011</year><volume>10</volume><fpage>453</fpage><lpage>471</lpage><pub-id pub-id-type="pmid">21629295</pub-id></mixed-citation></ref></ref-list></back><floats-group><fig id="fig1"><label>Figure 1</label><caption><p>Overview of all biological phases of platelet generation from HSCs and subsequent platelet activation. The abbreviated cell types are: CMP, common myeloid progenitor; BFU-E/MK, burst-forming unit erythrocyte/megakaryocyte; BFU-MK, burst-forming unit megakaryocyte; CFU-MK, colony-forming unit megakaryocyte</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cddis2013253f1"/></fig><fig id="fig2"><label>Figure 2</label><caption><p>The distribution of MKs in their niche. MK commitment from HSCs and differentiation into immature MKs occur in the osteoblastic niche. Proplatelets then adhere to the vasculature and ultimately release individual platelets from their tips after mature MKs migrate to the vascular niche. The abbreviated cell types are: CMP, common myeloid progenitor; BFU-MK, burst-forming unit megakaryocyte</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cddis2013253f2"/></fig><fig id="fig3"><label>Figure 3</label><caption><p>Nicotinamide-adenine dinucleotide phosphate (NADPH) oxidase-dependent ROS production is required for all phases of megakaryocytopoiesis. ROS production or augmentation is stimulated by extracellular signals, such as cytokines, endogenous ROS, and other ligands. ROS is necessary for the complete activation of signalling pathways as a second messenger in the regulation of signal transduction during MK development, and ROS might be the central player during megakaryocytopoiesis</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cddis2013253f3"/></fig><fig id="fig4"><label>Figure 4</label><caption><p>Proposed ROS signalling cascades and cellular biological outcomes after ROS interact with NO to generate ONOO<sup>&#x02212;</sup></p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cddis2013253f4"/></fig></floats-group></article>